###begin article-title 0
###xml 136 139 <span type="species:ncbi:9606">Men</span>
Polymorphisms in the Low-Density Lipoprotein Receptor-Related Protein 5 (LRP5) Gene Are Associated with Peak Bone Mass in Non-sedentary Men: Results from the Odense Androgen Study
###end article-title 0
###begin title 1
Purpose
###end title 1
###begin p 2
###xml 210 213 <span type="species:ncbi:9606">men</span>
To investigate the impact of the Ala1330Val (rs3736228, exon 18) and Val667Met (rs4988321, exon 9) polymorphisms of the low-density lipoprotein receptor-related protein 5 (LRP5) gene on peak bone mass in young men.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 85 88 <span type="species:ncbi:9606">men</span>
The Odense Androgen Study (OAS) is a population-based study comprising 783 Caucasian men aged 20-30 years. Genotyping was performed using real-time polymerase chain reaction (PCR) or fluorescence polarization. Bone mineral density (BMD) measurements were performed using dual-energy X-ray absorptiometry.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 419 420 419 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 664 665 664 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1099 1100 1099 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 87 99 <span type="species:ncbi:9606">participants</span>
###xml 414 417 <span type="species:ncbi:9606">men</span>
The CC, CT, and TT genotypes in Ala1330Val were found in 75.6%, 21.8%, and 2.6% of the participants, respectively. Similarly, the GG, GA, and AA genotypes of Val667Met were found in 89.7%, 9.8%, and 0.5%, respectively. For the Ala1330Val polymorphism, no significant differences between the genotypes were found regarding BMD in the overall study population. However, when analysis was restricted to non-sedentary men (n = 589), a significant association between the number of T-alleles and BMD in the spine and whole body were found. Each copy of the T-allele changed the Z-score of the spine by (median and 95% confidence interval) -0.21 [95% CI: -0.40; -0.03] (p < 0.02). Analysis suggested an association between the AA genotype in the Val667Met polymorphism and increased body height and decreased BMD of the femoral neck; however, no significant gene-dose effect of the A-allele could be demonstrated in the whole population. When the analysis was restricted to non-sedentary subjects, however, each number of A-alleles was associated with a change in Z-score of -0.26 [95% CI: -0.51; -0.01] (p = 0.04). No further significant results emerged with haplotype analysis.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 130 133 <span type="species:ncbi:9606">men</span>
The Ala1330Val and Val667Met polymorphisms in the LRP5 gene are significantly associated with peak bone mass in physically active men.
###end p 8
###begin title 9
Keywords
###end title 9
###begin p 10
###xml 169 170 169 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 171 172 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 154 159 <span type="species:ncbi:9606">women</span>
###xml 164 167 <span type="species:ncbi:9606">men</span>
Family and twin studies have demonstrated that genetic factors account for 50-80% of the inter-individual variation in bone mineral density (BMD) in both women and men [1-9]. Polymorphisms in a number of genes affect the bone phenotype regarding BMD, bone size, or fracture risk [10]. Only a small part of the overall variation in BMD, however, has been explained by the polymorphisms identified so far.
###end p 10
###begin p 11
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 585 587 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 685 687 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 476 491 <span type="species:ncbi:10090">transgenic mice</span>
###xml 748 752 <span type="species:ncbi:10090">mice</span>
The transmembrane proteins low-density lipoprotein receptor-related protein 5 (LRP5) and LRP6 are essential in Wnt signaling. They are expressed in many tissues including osteoblasts and have been implicated in the adaptive response of bone to mechanical load [11]. Located on chromosome 11q12-14, activating mutations in the LRP5 gene are responsible for rare conditions with a "high bone mass phenotype" [12, 13] as well as autosomal dominant osteopetrosis type 1 [14], and transgenic mice carrying the LRP5 G171V mutation have increased bone mass and bone biomechanical properties [15]. Conversely, inactivating mutations are responsible for the osteoporosis pseudoglioma syndrome [16] and this syndrome is recapitulated by LRP5 inactivation in mice [17].
###end p 11
###begin p 12
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 498 500 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 604 606 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 797 799 797 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 985 987 985 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 1036 1038 1036 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 1205 1207 1205 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 1408 1410 1408 1410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 1582 1584 1582 1584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 1585 1587 1585 1587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 1589 1591 1589 1591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 224 228 <span type="species:ncbi:9606">boys</span>
###xml 314 319 <span type="species:ncbi:9606">women</span>
###xml 348 351 <span type="species:ncbi:9606">men</span>
###xml 461 466 <span type="species:ncbi:9606">women</span>
###xml 493 496 <span type="species:ncbi:9606">men</span>
###xml 589 592 <span type="species:ncbi:9606">men</span>
###xml 597 602 <span type="species:ncbi:9606">women</span>
###xml 723 727 <span type="species:ncbi:9606">boys</span>
###xml 739 744 <span type="species:ncbi:9606">girls</span>
###xml 1031 1034 <span type="species:ncbi:9606">men</span>
In addition to these mutations, a number of polymorphisms have been described in the LRP5 gene (). One of these, the Ala1330Val (rs3736228, exon 18) polymorphism, has been associated with attenuated bone gain in prepubertal boys [18], decreased BMD in Japanese [19], American [20], Australian [21], and Dutch [22] women as well as in elderly Dutch men [22]. It has also been associated with an increased risk of fragility fractures in postmenopausal Australian women [21] and in elderly Dutch men [22]. No association, however, was found between this polymorphism and bone loss in elderly men and women [22]. Similarly, the Val667Met (rs4988321, exon 9) polymorphism was associated with attenuated bone gain in prepubertal boys but not in girls participating in a 1-year longitudinal Swiss study [18]. In the same study, this polymorphism was also associated with decreased lumbar spine bone mineral content and projected bone area and there was a trend toward lower BMD in the spine [18]. These associations were mainly driven by men [18] and in haplotype analysis including Ala1330Val, most of the effect was conferred by the Val667Met polymorphism. Moreover, in a case-control study by Ferrari et al. [23] on idiopathic osteoporosis in males, both LRP5 polymorphisms significantly increased the odds ratio for osteoporosis. Additionally, Val667Met was associated with low stature in adults of both sexes [18]. Thus, current evidence suggests that polymorphisms in the LRP5 gene may be involved in the control of peak bone mass and may increase the risk of osteoporosis in males [16,18, 23].
###end p 12
###begin p 13
###xml 127 130 <span type="species:ncbi:9606">men</span>
In the present study, we investigated the association between the Ala1330Val and Val667Met polymorphisms and peak bone mass in men in a population-based study.
###end p 13
###begin title 14
Subjects and Methods
###end title 14
###begin p 15
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 203 206 <span type="species:ncbi:9606">men</span>
###xml 247 259 <span type="species:ncbi:9606">participants</span>
###xml 305 308 <span type="species:ncbi:9606">men</span>
###xml 639 642 <span type="species:ncbi:9606">men</span>
###xml 782 785 <span type="species:ncbi:9606">men</span>
###xml 882 885 <span type="species:ncbi:9606">men</span>
###xml 1158 1161 <span type="species:ncbi:9606">men</span>
###xml 1211 1214 <span type="species:ncbi:9606">men</span>
###xml 1281 1293 <span type="species:ncbi:9606">participants</span>
The Odense Androgen Study (OAS) is a population-based, prospective, observational study on the interrelationship between endocrine status, body composition, muscle function, and bone metabolism in young men. Details on the design and inclusion of participants are reported elsewhere [24]. In brief, 3,000 men aged 20-30 years were randomly selected from the civil registration database in Fuenen County, Denmark, and invited by mail to participate in the study. These subjects also received a questionnaire regarding smoking, medication, chronic diseases, drug abuse, etc. A total of 2,042 questionnaires were returned, and from these 859 men expressed interest in participation in the clinical part of the study. Nineteen withdrew before an appointment for inclusion was made. Ten men did not meet with the inclusion criteria (Caucasian and age between 20-29 years), and another 3 men gave their notice after the inclusion had stopped. Aside from these latecomers none of the responders were excluded. Of the remaining 827 eligible subjects, 43 did not attend for their appointment and did not wish to reschedule, but informed consent was obtained from 784 men, with dropout from 1 subject. Thus 783 Caucasian men gave written informed consent and were included in the OAS. These participants had similar age, body mass index (BMI), lifestyle, socio-economic status, and educational level as the background population, as evaluated by questionnaires and demographic data (manuscript in preparation). The protocol stipulated that subjects with massive substance or alcohol abuse, malignant disease or severe chronic disease be excluded; however, none of the responders fulfilled any of these criteria. The study was approved by the local Ethics Committee of Fuenen and Vejle Counties (file number 20010198), conducted according to the Helsinki Declaration, and declared in ClinicalTrials.gov: NCT00150163, registered September 6, 2005.
###end p 15
###begin title 16
Genotyping
###end title 16
###begin p 17
DNA was isolated from whole blood samples using QIAamp DNA Blood Midi kits (Qiagen, Valencia, CA, USA).
###end p 17
###begin p 18
###xml 143 174 143 174 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="19">Sense: 5&#8242;-GACGGCGAGGCAGACTGT-3&#8242;</p>
###xml 143 174 143 174 <list-item xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="19">Sense: 5&#8242;-GACGGCGAGGCAGACTGT-3&#8242;</p></list-item>
###xml 174 208 174 208 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="20">Antisense: 5&#8242;-GCAGGGCCAGGGTCTTG-3&#8242;</p>
###xml 174 208 174 208 <list-item xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="20">Antisense: 5&#8242;-GCAGGGCCAGGGTCTTG-3&#8242;</p></list-item>
###xml 208 247 208 247 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="21">C probe: 5&#8242;-FAM-TCAAAGTCCGCCTCGT-NFQ-3&#8242;</p>
###xml 208 247 208 247 <list-item xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="21">C probe: 5&#8242;-FAM-TCAAAGTCCGCCTCGT-NFQ-3&#8242;</p></list-item>
###xml 247 286 247 286 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="22">T probe: 5&#8242;-VIC-CACAGTCCACCTCGTC-NFQ-3&#8242;</p>
###xml 247 286 247 286 <list-item xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="22">T probe: 5&#8242;-VIC-CACAGTCCACCTCGTC-NFQ-3&#8242;</p></list-item>
###xml 143 286 143 286 <list xmlns:xlink="http://www.w3.org/1999/xlink" list-type="bullet"><list-item><p textid="19">Sense: 5&#8242;-GACGGCGAGGCAGACTGT-3&#8242;</p></list-item><list-item><p textid="20">Antisense: 5&#8242;-GCAGGGCCAGGGTCTTG-3&#8242;</p></list-item><list-item><p textid="21">C probe: 5&#8242;-FAM-TCAAAGTCCGCCTCGT-NFQ-3&#8242;</p></list-item><list-item><p textid="22">T probe: 5&#8242;-VIC-CACAGTCCACCTCGTC-NFQ-3&#8242;</p></list-item></list>
The Ala1330Val polymorphism was analyzed using Taqman primers and probes that were designed using Primer Express software (Applied Biosystems):Sense: 5'-GACGGCGAGGCAGACTGT-3'Antisense: 5'-GCAGGGCCAGGGTCTTG-3'C probe: 5'-FAM-TCAAAGTCCGCCTCGT-NFQ-3'T probe: 5'-VIC-CACAGTCCACCTCGTC-NFQ-3'The real-time analysis was performed using the ABI PRISM 7700 Sequence Detection System. To validate the method, approximately 10% of the samples were repeated and in total 17 samples-at least 5 of each genotype-were sequenced.
###end p 18
###begin p 19
Sense: 5'-GACGGCGAGGCAGACTGT-3'
###end p 19
###begin p 20
Antisense: 5'-GCAGGGCCAGGGTCTTG-3'
###end p 20
###begin p 21
C probe: 5'-FAM-TCAAAGTCCGCCTCGT-NFQ-3'
###end p 21
###begin p 22
T probe: 5'-VIC-CACAGTCCACCTCGTC-NFQ-3'
###end p 22
###begin p 23
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 304 336 304 336 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="24">Sense: 5-gccTTcTTggTcTTcAccAg-3&#8242;</p>
###xml 304 336 304 336 <list-item xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="24">Sense: 5-gccTTcTTggTcTTcAccAg-3&#8242;</p></list-item>
###xml 336 373 336 373 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="25">Antisense: 5&#8242;-cTTTgAggcAggAAcAgAgg-3&#8242;</p>
###xml 336 373 336 373 <list-item xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="25">Antisense: 5&#8242;-cTTTgAggcAggAAcAgAgg-3&#8242;</p></list-item>
###xml 304 373 304 373 <list xmlns:xlink="http://www.w3.org/1999/xlink" list-type="bullet"><list-item><p textid="24">Sense: 5-gccTTcTTggTcTTcAccAg-3&#8242;</p></list-item><list-item><p textid="25">Antisense: 5&#8242;-cTTTgAggcAggAAcAgAgg-3&#8242;</p></list-item></list>
The Val667Met polymorphism was analyzed using fluorescence polarization as described previously [25], using AcycloPrime-FP SNP Detection kits (Perkin Elmer Life Sciences, Boston, MA, USA). PCR fragments containing the polymorphisms were generated using standard conditions with the following PCR primers:Sense: 5-gccTTcTTggTcTTcAccAg-3'Antisense: 5'-cTTTgAggcAggAAcAgAgg-3'Enzymatic clean-up and subsequent AcycloPrime-FP reaction with SNP primer (sense 5'-ccTcgAgAccAATAAcAAcgAc-3') were performed according to the instructions of the kit manufacturer. Fluorescence polarization was read in a Wallac Victor multilabel plate reader (Perkin Elmer Life Sciences, Boston, MA, USA). Blank samples and samples with known genotype were included as negative and positive controls, respectively. A total of 10% of all samples were sequenced and genotyping confirmed in all cases.
###end p 23
###begin p 24
Sense: 5-gccTTcTTggTcTTcAccAg-3'
###end p 24
###begin p 25
Antisense: 5'-cTTTgAggcAggAAcAgAgg-3'
###end p 25
###begin title 26
Anthropometrics and Lifestyle
###end title 26
###begin p 27
Body weight, body height, sitting height, and arm span were measured. Data regarding exercise habits were collected using a self-administered questionnaire. Non-sedentary lifestyle was defined as participation in any form of regular exercise.
###end p 27
###begin title 28
Dual-Energy X-ray Absorptiometry (DXA)
###end title 28
###begin p 29
BMD of the lumbar spine, hip, and whole-body was measured using a Hologic 4500 DXA-scanner (Waltham, MA, USA). The coefficient of variation (CV) for BMD is 1.5%, 1.5%, and 0.7% in the lumbar spine, total hip, and whole body, respectively. Lean body mass (LBM) and fat mass was obtained from the whole-body scans.
###end p 29
###begin title 30
Biochemistry
###end title 30
###begin p 31
Serum samples were drawn after an overnight fast between 08.00 and 10.00 hours and stored for later analyses at -80degreesC. Serum concentrations of osteocalcin were measured by a luminoimmunoassay (BRAHMS Diagnostica, Berlin, Germany) with an intra-assay and inter-assay CV of 5% and 8%, respectively.
###end p 31
###begin p 32
###xml 706 708 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
Serum levels of type 1 collagen C-terminal telopeptide (1CTP) were measured using radioimmunoassay (RIA) (Orion Diagnostica, Espoo, Finland) with an intra-assay and inter-assay CV of 4% and 6%, respectively. Bone-specific alkaline phosphatase (bone-AP) concentration in serum was determined enzymatically after monoclonal antibody capture (Metra Biosystems, Mountain View, CA, USA). The intra-assay CV was 2% and the inter-assay CV 12% for this analysis. Serum levels of 25-OH-vitamin D were measured using a competitive radioimmunoassay (DiaSorin, Stillwater, MN, USA) with an intra-assay CV of 6% and an inter-assay CV of 15%. Serum IGF-I was determined in acid-ethanol extracts as described previously [26]. Intra- and inter-assay variation averaged less than 5% and less than 10%, respectively.
###end p 32
###begin title 33
Statistics
###end title 33
###begin p 34
###xml 338 339 336 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 402 404 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 492 494 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
###xml 569 570 567 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 784 785 782 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Data are reported as the mean +/- SD, median (range), or median [95% CI], as appropriate. BMD values are shown in absolute values. Regarding the allele dose-analyses, BMD values were transformed to Z-scores using the SD observed in our population. Hardy-Weinberg equilibrium was checked using chi-square analysis. Linkage disequilibrium (D') between polymorphisms was evaluated by using GOLD software [27]. Haplotype analysis was undertaken using FAMHAP software for constructing haplotypes [28]. Comparisons between groups were performed using one-way ANOVA, unpaired t-test or similar nonparametric tests. Associations between parameters were analyzed using Pearson's regression analysis and multiple linear regression analysis. Dichotomies were tested using the chi-square test. A p value of less than 0.05 was considered significant. Statistical analyses were performed using SPSS 11.5 and SPSS 12.0.
###end p 34
###begin title 35
Results
###end title 35
###begin title 36
Genotype Frequencies
###end title 36
###begin p 37
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 240 247 240 247 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 247 362 247 362 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="38">Covariates, BMD, and lifestyle (sedentary/non-sedentary) by LRP5 genotypes (Ala1330Val and Val667Met polymorphisms)</p>
###xml 247 362 247 362 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="38">Covariates, BMD, and lifestyle (sedentary/non-sedentary) by LRP5 genotypes (Ala1330Val and Val667Met polymorphisms)</p></caption>
###xml 362 362 362 362 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 362 375 362 375 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="8">Polymorphisms</th>
###xml 362 375 362 375 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left"/><th align="left" colspan="8">Polymorphisms</th></tr>
###xml 375 375 375 375 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 375 385 375 385 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="4">Ala1330Val</th>
###xml 385 394 385 394 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="4">Val667Met</th>
###xml 375 394 375 394 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left"/><th align="left" colspan="4">Ala1330Val</th><th align="left" colspan="4">Val667Met</th></tr>
###xml 394 394 394 394 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 394 396 394 396 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">CC</th>
###xml 396 398 396 398 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">CT</th>
###xml 398 400 398 400 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">TT</th>
###xml 400 401 400 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 400 416 400 416 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>p</italic> values (ANOVA)</th>
###xml 416 418 416 418 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">GG</th>
###xml 418 420 418 420 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">GA</th>
###xml 420 422 420 422 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">AA</th>
###xml 422 423 422 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 422 438 422 438 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>p</italic> values (ANOVA)</th>
###xml 394 438 394 438 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left"/><th align="left">CC</th><th align="left">CT</th><th align="left">TT</th><th align="left"><italic>p</italic> values (ANOVA)</th><th align="left">GG</th><th align="left">GA</th><th align="left">AA</th><th align="left"><italic>p</italic> values (ANOVA)</th></tr>
###xml 362 438 362 438 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left"/><th align="left" colspan="8">Polymorphisms</th></tr><tr><th align="left"/><th align="left" colspan="4">Ala1330Val</th><th align="left" colspan="4">Val667Met</th></tr><tr><th align="left"/><th align="left">CC</th><th align="left">CT</th><th align="left">TT</th><th align="left"><italic>p</italic> values (ANOVA)</th><th align="left">GG</th><th align="left">GA</th><th align="left">AA</th><th align="left"><italic>p</italic> values (ANOVA)</th></tr></thead>
###xml 438 439 438 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 438 439 438 439 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>n</italic></td>
###xml 439 442 439 442 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">589</td>
###xml 442 445 442 445 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">170</td>
###xml 445 447 445 447 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">20</td>
###xml 447 448 447 448 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 448 451 448 451 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">699</td>
###xml 451 453 451 453 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">76</td>
###xml 453 454 453 454 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">4</td>
###xml 454 455 454 455 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 438 455 438 455 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>n</italic></td><td align="left">589</td><td align="left">170</td><td align="left">20</td><td align="left">&#8211;</td><td align="left">699</td><td align="left">76</td><td align="left">4</td><td align="left">&#8211;</td></tr>
###xml 455 466 455 466 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Age (years)</td>
###xml 466 478 466 476 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">25.5&#160;&#177;&#160;2.8</td>
###xml 478 490 476 486 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">25.3&#160;&#177;&#160;2.8</td>
###xml 490 502 486 496 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">25.9&#160;&#177;&#160;2.7</td>
###xml 502 504 496 498 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 504 516 498 508 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">25.5&#160;&#177;&#160;2.8</td>
###xml 516 528 508 518 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">25.3&#160;&#177;&#160;2.6</td>
###xml 528 540 518 528 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">27.0&#160;&#177;&#160;1.8</td>
###xml 540 542 528 530 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 455 542 455 530 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Age (years)</td><td align="left">25.5&#160;&#177;&#160;2.8</td><td align="left">25.3&#160;&#177;&#160;2.8</td><td align="left">25.9&#160;&#177;&#160;2.7</td><td align="left">NS</td><td align="left">25.5&#160;&#177;&#160;2.8</td><td align="left">25.3&#160;&#177;&#160;2.6</td><td align="left">27.0&#160;&#177;&#160;1.8</td><td align="left">NS</td></tr>
###xml 542 558 530 546 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Body height (cm)</td>
###xml 558 571 546 557 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">181.7&#160;&#177;&#160;6.8</td>
###xml 571 584 557 568 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">181.5&#160;&#177;&#160;6.1</td>
###xml 584 597 568 579 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">182.8&#160;&#177;&#160;7.7</td>
###xml 597 599 579 581 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 599 612 581 592 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">181.7&#160;&#177;&#160;6.8</td>
###xml 612 625 592 603 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">181.3&#160;&#177;&#160;5.6</td>
###xml 625 638 603 614 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">190.7&#160;&#177;&#160;6.3</td>
###xml 638 642 614 618 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.02</td>
###xml 542 642 530 618 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Body height (cm)</td><td align="left">181.7&#160;&#177;&#160;6.8</td><td align="left">181.5&#160;&#177;&#160;6.1</td><td align="left">182.8&#160;&#177;&#160;7.7</td><td align="left">NS</td><td align="left">181.7&#160;&#177;&#160;6.8</td><td align="left">181.3&#160;&#177;&#160;5.6</td><td align="left">190.7&#160;&#177;&#160;6.3</td><td align="left">0.02</td></tr>
###xml 642 655 618 631 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Arm span (cm)</td>
###xml 655 669 631 643 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">183.4&#160;&#177;&#160;8.2 </td>
###xml 669 682 643 654 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">183.1&#160;&#177;&#160;7.0</td>
###xml 682 695 654 665 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">185.4&#160;&#177;&#160;8.9</td>
###xml 695 697 665 667 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 697 710 667 678 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">183.3&#160;&#177;&#160;8.0</td>
###xml 710 723 678 689 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">182.6&#160;&#177;&#160;6.9</td>
###xml 723 736 689 700 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">193.5&#160;&#177;&#160;6.8</td>
###xml 736 740 700 704 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.04</td>
###xml 642 740 618 704 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Arm span (cm)</td><td align="left">183.4&#160;&#177;&#160;8.2 </td><td align="left">183.1&#160;&#177;&#160;7.0</td><td align="left">185.4&#160;&#177;&#160;8.9</td><td align="left">NS</td><td align="left">183.3&#160;&#177;&#160;8.0</td><td align="left">182.6&#160;&#177;&#160;6.9</td><td align="left">193.5&#160;&#177;&#160;6.8</td><td align="left">0.04</td></tr>
###xml 740 756 704 720 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Body weight (kg)</td>
###xml 756 769 720 731 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">81.9&#160;&#177;&#160;11.8</td>
###xml 769 782 731 742 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">81.1&#160;&#177;&#160;12.4</td>
###xml 782 795 742 753 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">85.9&#160;&#177;&#160;16.7</td>
###xml 795 797 753 755 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 797 810 755 766 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">81.7&#160;&#177;&#160;12.1</td>
###xml 810 823 766 777 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">82.2&#160;&#177;&#160;12.9</td>
###xml 823 836 777 788 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">90.4&#160;&#177;&#160;12.2</td>
###xml 836 838 788 790 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 740 838 704 790 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Body weight (kg)</td><td align="left">81.9&#160;&#177;&#160;11.8</td><td align="left">81.1&#160;&#177;&#160;12.4</td><td align="left">85.9&#160;&#177;&#160;16.7</td><td align="left">NS</td><td align="left">81.7&#160;&#177;&#160;12.1</td><td align="left">82.2&#160;&#177;&#160;12.9</td><td align="left">90.4&#160;&#177;&#160;12.2</td><td align="left">NS</td></tr>
###xml 859 860 811 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 838 861 790 813 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Body mass index (kg/m<sup>2</sup>)</td>
###xml 861 873 813 823 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">24.8&#160;&#177;&#160;3.3</td>
###xml 873 885 823 833 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">24.6&#160;&#177;&#160;3.7</td>
###xml 885 897 833 843 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">25.6&#160;&#177;&#160;4.1</td>
###xml 897 899 843 845 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 899 911 845 855 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">24.8&#160;&#177;&#160;3.3</td>
###xml 911 923 855 865 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">25.1&#160;&#177;&#160;4.3</td>
###xml 923 935 865 875 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">24.8&#160;&#177;&#160;1.8</td>
###xml 935 937 875 877 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 838 937 790 877 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Body mass index (kg/m<sup>2</sup>)</td><td align="left">24.8&#160;&#177;&#160;3.3</td><td align="left">24.6&#160;&#177;&#160;3.7</td><td align="left">25.6&#160;&#177;&#160;4.1</td><td align="left">NS</td><td align="left">24.8&#160;&#177;&#160;3.3</td><td align="left">25.1&#160;&#177;&#160;4.3</td><td align="left">24.8&#160;&#177;&#160;1.8</td><td align="left">NS</td></tr>
###xml 937 956 877 896 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Total fat mass (kg)</td>
###xml 956 968 896 906 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">14.9&#160;&#177;&#160;6.2</td>
###xml 968 980 906 916 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">14.9&#160;&#177;&#160;7.3</td>
###xml 980 992 916 926 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">17.7&#160;&#177;&#160;8.5</td>
###xml 992 994 926 928 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 994 1006 928 938 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">15.3&#160;&#177;&#160;6.2</td>
###xml 1006 1018 938 948 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">15.1&#160;&#177;&#160;6.7</td>
###xml 1018 1030 948 958 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">17.9&#160;&#177;&#160;7.9</td>
###xml 1030 1032 958 960 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 937 1032 877 960 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Total fat mass (kg)</td><td align="left">14.9&#160;&#177;&#160;6.2</td><td align="left">14.9&#160;&#177;&#160;7.3</td><td align="left">17.7&#160;&#177;&#160;8.5</td><td align="left">NS</td><td align="left">15.3&#160;&#177;&#160;6.2</td><td align="left">15.1&#160;&#177;&#160;6.7</td><td align="left">17.9&#160;&#177;&#160;7.9</td><td align="left">NS</td></tr>
###xml 1032 1051 960 979 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Lean body mass (kg)</td>
###xml 1051 1063 979 989 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">64.0&#160;&#177;&#160;7.3</td>
###xml 1063 1075 989 999 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">63.3&#160;&#177;&#160;6.8</td>
###xml 1075 1087 999 1009 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">65.3&#160;&#177;&#160;9.0</td>
###xml 1087 1089 1009 1011 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 1089 1102 1011 1022 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">64.7&#160;&#177;&#160;6.9 </td>
###xml 1102 1114 1022 1032 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">64.4&#160;&#177;&#160;6.0</td>
###xml 1114 1126 1032 1042 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">70.4&#160;&#177;&#160;7.0</td>
###xml 1126 1128 1042 1044 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 1032 1128 960 1044 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Lean body mass (kg)</td><td align="left">64.0&#160;&#177;&#160;7.3</td><td align="left">63.3&#160;&#177;&#160;6.8</td><td align="left">65.3&#160;&#177;&#160;9.0</td><td align="left">NS</td><td align="left">64.7&#160;&#177;&#160;6.9 </td><td align="left">64.4&#160;&#177;&#160;6.0</td><td align="left">70.4&#160;&#177;&#160;7.0</td><td align="left">NS</td></tr>
###xml 1148 1149 1064 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1128 1150 1044 1066 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Units alcohol/week (<italic>n</italic>)</td>
###xml 1150 1163 1066 1077 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">11.4&#160;&#177;&#160;10.2</td>
###xml 1163 1175 1077 1087 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">10.7&#160;&#177;&#160;8.6</td>
###xml 1175 1187 1087 1097 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">12.3&#160;&#177;&#160;8.7</td>
###xml 1187 1189 1097 1099 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 1189 1201 1099 1109 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">11.0&#160;&#177;&#160;9.4</td>
###xml 1201 1213 1109 1119 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">10.8&#160;&#177;&#160;8.1</td>
###xml 1213 1224 1119 1128 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">6.5&#160;&#177;&#160;7.3</td>
###xml 1224 1226 1128 1130 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 1128 1226 1044 1130 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Units alcohol/week (<italic>n</italic>)</td><td align="left">11.4&#160;&#177;&#160;10.2</td><td align="left">10.7&#160;&#177;&#160;8.6</td><td align="left">12.3&#160;&#177;&#160;8.7</td><td align="left">NS</td><td align="left">11.0&#160;&#177;&#160;9.4</td><td align="left">10.8&#160;&#177;&#160;8.1</td><td align="left">6.5&#160;&#177;&#160;7.3</td><td align="left">NS</td></tr>
###xml 1242 1243 1146 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1226 1244 1130 1148 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Cigarettes/day (<italic>n</italic>)</td>
###xml 1244 1252 1148 1156 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0 [0&#8211;45]</td>
###xml 1252 1260 1156 1164 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0 [0&#8211;35]</td>
###xml 1260 1268 1164 1172 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0 [0&#8211;25]</td>
###xml 1268 1270 1172 1174 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 1270 1278 1174 1182 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0 [0&#8211;35]</td>
###xml 1278 1286 1182 1190 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0 [0&#8211;30]</td>
###xml 1286 1293 1190 1197 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0 [0&#8211;1]</td>
###xml 1293 1295 1197 1199 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 1226 1295 1130 1199 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Cigarettes/day (<italic>n</italic>)</td><td align="left">0 [0&#8211;45]</td><td align="left">0 [0&#8211;35]</td><td align="left">0 [0&#8211;25]</td><td align="left">NS</td><td align="left">0 [0&#8211;35]</td><td align="left">0 [0&#8211;30]</td><td align="left">0 [0&#8211;1]</td><td align="left">NS</td></tr>
###xml 1308 1309 1212 1213 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1295 1318 1199 1222 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Serum 25-OH-D<sub>3</sub> (nmol/l)</td>
###xml 1318 1331 1222 1233 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">65.1&#160;&#177;&#160;27.9</td>
###xml 1331 1344 1233 1244 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">64.2&#160;&#177;&#160;26.9</td>
###xml 1344 1357 1244 1255 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">67.9&#160;&#177;&#160;28.6</td>
###xml 1357 1359 1255 1257 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 1359 1372 1257 1268 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">65.2&#160;&#177;&#160;27.5</td>
###xml 1372 1385 1268 1279 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">63.0&#160;&#177;&#160;29.1</td>
###xml 1385 1398 1279 1290 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">60.0&#160;&#177;&#160;25.4</td>
###xml 1398 1400 1290 1292 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 1295 1400 1199 1292 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Serum 25-OH-D<sub>3</sub> (nmol/l)</td><td align="left">65.1&#160;&#177;&#160;27.9</td><td align="left">64.2&#160;&#177;&#160;26.9</td><td align="left">67.9&#160;&#177;&#160;28.6</td><td align="left">NS</td><td align="left">65.2&#160;&#177;&#160;27.5</td><td align="left">63.0&#160;&#177;&#160;29.1</td><td align="left">60.0&#160;&#177;&#160;25.4</td><td align="left">NS</td></tr>
###xml 1400 1419 1292 1310 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Serum IGF-I (&#956;g/l)</td>
###xml 1419 1433 1310 1322 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">199.9&#160;&#177;&#160;52.8</td>
###xml 1433 1447 1322 1334 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">202.4&#160;&#177;&#160;50.3</td>
###xml 1447 1461 1334 1346 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">191.0&#160;&#177;&#160;36.1</td>
###xml 1461 1463 1346 1348 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 1463 1475 1348 1358 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">27.6&#160;&#177;&#160;7.5</td>
###xml 1475 1487 1358 1368 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">25.5&#160;&#177;&#160;6.6</td>
###xml 1487 1499 1368 1378 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">27.3&#160;&#177;&#160;7.8</td>
###xml 1499 1501 1378 1380 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 1400 1501 1292 1380 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Serum IGF-I (&#956;g/l)</td><td align="left">199.9&#160;&#177;&#160;52.8</td><td align="left">202.4&#160;&#177;&#160;50.3</td><td align="left">191.0&#160;&#177;&#160;36.1</td><td align="left">NS</td><td align="left">27.6&#160;&#177;&#160;7.5</td><td align="left">25.5&#160;&#177;&#160;6.6</td><td align="left">27.3&#160;&#177;&#160;7.8</td><td align="left">NS</td></tr>
###xml 1501 1527 1380 1406 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Serum osteocalcin (mmol/l)</td>
###xml 1527 1538 1406 1415 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3.0&#160;&#177;&#160;1.1</td>
###xml 1538 1549 1415 1424 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3.1&#160;&#177;&#160;1.3</td>
###xml 1549 1560 1424 1433 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3.0&#160;&#177;&#160;1.0</td>
###xml 1560 1562 1433 1435 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 1562 1573 1435 1444 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3.1&#160;&#177;&#160;1.2</td>
###xml 1573 1584 1444 1453 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2.8&#160;&#177;&#160;1.0</td>
###xml 1584 1595 1453 1462 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2.3&#160;&#177;&#160;0.5</td>
###xml 1595 1597 1462 1464 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 1501 1597 1380 1464 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Serum osteocalcin (mmol/l)</td><td align="left">3.0&#160;&#177;&#160;1.1</td><td align="left">3.1&#160;&#177;&#160;1.3</td><td align="left">3.0&#160;&#177;&#160;1.0</td><td align="left">NS</td><td align="left">3.1&#160;&#177;&#160;1.2</td><td align="left">2.8&#160;&#177;&#160;1.0</td><td align="left">2.3&#160;&#177;&#160;0.5</td><td align="left">NS</td></tr>
###xml 1597 1615 1464 1481 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Serum 1CTP (&#956;g/l)</td>
###xml 1615 1626 1481 1490 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5.0&#160;&#177;&#160;1.4</td>
###xml 1626 1637 1490 1499 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">4.9&#160;&#177;&#160;1,5</td>
###xml 1637 1648 1499 1508 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5.1&#160;&#177;&#160;1.3</td>
###xml 1648 1650 1508 1510 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 1650 1661 1510 1519 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5.0&#160;&#177;&#160;1.4</td>
###xml 1661 1672 1519 1528 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">4.9&#160;&#177;&#160;1.4</td>
###xml 1672 1683 1528 1537 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">4.9&#160;&#177;&#160;0.9</td>
###xml 1683 1685 1537 1539 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 1597 1685 1464 1539 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Serum 1CTP (&#956;g/l)</td><td align="left">5.0&#160;&#177;&#160;1.4</td><td align="left">4.9&#160;&#177;&#160;1,5</td><td align="left">5.1&#160;&#177;&#160;1.3</td><td align="left">NS</td><td align="left">5.0&#160;&#177;&#160;1.4</td><td align="left">4.9&#160;&#177;&#160;1.4</td><td align="left">4.9&#160;&#177;&#160;0.9</td><td align="left">NS</td></tr>
###xml 1685 1698 1539 1552 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Bone-AP (U/l)</td>
###xml 1698 1711 1552 1563 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">26. 6&#160;&#177;&#160;8.1</td>
###xml 1711 1724 1563 1574 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">28.4&#160;&#177;&#160;10.0</td>
###xml 1724 1736 1574 1584 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">26.7&#160;&#177;&#160;8.3</td>
###xml 1736 1738 1584 1586 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 1738 1750 1586 1596 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">26.7&#160;&#177;&#160;8.2</td>
###xml 1750 1762 1596 1606 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">25.8&#160;&#177;&#160;7.0</td>
###xml 1762 1775 1606 1617 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">33.4&#160;&#177;&#160;16.4</td>
###xml 1775 1777 1617 1619 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 1685 1777 1539 1619 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Bone-AP (U/l)</td><td align="left">26. 6&#160;&#177;&#160;8.1</td><td align="left">28.4&#160;&#177;&#160;10.0</td><td align="left">26.7&#160;&#177;&#160;8.3</td><td align="left">NS</td><td align="left">26.7&#160;&#177;&#160;8.2</td><td align="left">25.8&#160;&#177;&#160;7.0</td><td align="left">33.4&#160;&#177;&#160;16.4</td><td align="left">NS</td></tr>
###xml 1780 1785 1622 1627 <sub xmlns:xlink="http://www.w3.org/1999/xlink">spine</sub>
###xml 1791 1792 1633 1634 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1777 1793 1619 1635 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">BMD<sub>spine</sub> (g/cm<sup>2</sup>)</td>
###xml 1793 1806 1635 1646 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.08&#160;&#177;&#160;0.12</td>
###xml 1806 1819 1646 1657 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.07&#160;&#177;&#160;0.17</td>
###xml 1819 1832 1657 1668 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.05&#160;&#177;&#160;0.13</td>
###xml 1832 1834 1668 1670 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 1834 1847 1670 1681 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.08&#160;&#177;&#160;0.12</td>
###xml 1847 1860 1681 1692 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.07&#160;&#177;&#160;0.22</td>
###xml 1860 1873 1692 1703 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.07&#160;&#177;&#160;0.15</td>
###xml 1873 1875 1703 1705 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 1777 1875 1619 1705 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">BMD<sub>spine</sub> (g/cm<sup>2</sup>)</td><td align="left">1.08&#160;&#177;&#160;0.12</td><td align="left">1.07&#160;&#177;&#160;0.17</td><td align="left">1.05&#160;&#177;&#160;0.13</td><td align="left">NS</td><td align="left">1.08&#160;&#177;&#160;0.12</td><td align="left">1.07&#160;&#177;&#160;0.22</td><td align="left">1.07&#160;&#177;&#160;0.15</td><td align="left">NS</td></tr>
###xml 1878 1881 1708 1711 <sub xmlns:xlink="http://www.w3.org/1999/xlink">hip</sub>
###xml 1887 1888 1717 1718 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1875 1889 1705 1719 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">BMD<sub>hip</sub> (g/cm<sup>2</sup>)</td>
###xml 1889 1902 1719 1730 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.95&#160;&#177;&#160;0.14</td>
###xml 1902 1915 1730 1741 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.94&#160;&#177;&#160;0.14</td>
###xml 1915 1928 1741 1752 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.94&#160;&#177;&#160;0.15</td>
###xml 1928 1930 1752 1754 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 1930 1943 1754 1765 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.95&#160;&#177;&#160;0.14</td>
###xml 1943 1956 1765 1776 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.96&#160;&#177;&#160;0.15</td>
###xml 1956 1969 1776 1787 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.84&#160;&#177;&#160;0.07</td>
###xml 1969 1973 1787 1791 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.03</td>
###xml 1875 1973 1705 1791 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">BMD<sub>hip</sub> (g/cm<sup>2</sup>)</td><td align="left">0.95&#160;&#177;&#160;0.14</td><td align="left">0.94&#160;&#177;&#160;0.14</td><td align="left">0.94&#160;&#177;&#160;0.15</td><td align="left">NS</td><td align="left">0.95&#160;&#177;&#160;0.14</td><td align="left">0.96&#160;&#177;&#160;0.15</td><td align="left">0.84&#160;&#177;&#160;0.07</td><td align="left">0.03</td></tr>
###xml 1976 1978 1794 1796 <sub xmlns:xlink="http://www.w3.org/1999/xlink">WB</sub>
###xml 1984 1985 1802 1803 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1973 1986 1791 1804 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">BMD<sub>WB</sub> (g/cm<sup>2</sup>)</td>
###xml 1986 2000 1804 1816 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.22&#160;&#177;&#160;0.10*</td>
###xml 2000 2013 1816 1827 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.21&#160;&#177;&#160;0.09</td>
###xml 2013 2026 1827 1838 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.21&#160;&#177;&#160;0.11</td>
###xml 2026 2028 1838 1840 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 2028 2041 1840 1851 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.22&#160;&#177;&#160;0.10</td>
###xml 2041 2054 1851 1862 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.21&#160;&#177;&#160;0.11</td>
###xml 2054 2067 1862 1873 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.20&#160;&#177;&#160;0.08</td>
###xml 2067 2069 1873 1875 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 1973 2069 1791 1875 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">BMD<sub>WB</sub> (g/cm<sup>2</sup>)</td><td align="left">1.22&#160;&#177;&#160;0.10*</td><td align="left">1.21&#160;&#177;&#160;0.09</td><td align="left">1.21&#160;&#177;&#160;0.11</td><td align="left">NS</td><td align="left">1.22&#160;&#177;&#160;0.10</td><td align="left">1.21&#160;&#177;&#160;0.11</td><td align="left">1.20&#160;&#177;&#160;0.08</td><td align="left">NS</td></tr>
###xml 2094 2095 1900 1901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 2069 2096 1875 1902 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Sedentary/non-sedentary (<italic>n</italic>)</td>
###xml 2096 2103 1902 1909 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">150/440</td>
###xml 2103 2109 1909 1915 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">37/133</td>
###xml 2109 2113 1915 1919 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">4/16</td>
###xml 2113 2115 1919 1921 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 2115 2122 1921 1928 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">171/528</td>
###xml 2122 2127 1928 1933 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">18/58</td>
###xml 2127 2130 1933 1936 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1/3</td>
###xml 2130 2132 1936 1938 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 2069 2132 1875 1938 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Sedentary/non-sedentary (<italic>n</italic>)</td><td align="left">150/440</td><td align="left">37/133</td><td align="left">4/16</td><td align="left">NS</td><td align="left">171/528</td><td align="left">18/58</td><td align="left">1/3</td><td align="left">NS</td></tr>
###xml 438 2132 438 1938 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left"><italic>n</italic></td><td align="left">589</td><td align="left">170</td><td align="left">20</td><td align="left">&#8211;</td><td align="left">699</td><td align="left">76</td><td align="left">4</td><td align="left">&#8211;</td></tr><tr><td align="left">Age (years)</td><td align="left">25.5&#160;&#177;&#160;2.8</td><td align="left">25.3&#160;&#177;&#160;2.8</td><td align="left">25.9&#160;&#177;&#160;2.7</td><td align="left">NS</td><td align="left">25.5&#160;&#177;&#160;2.8</td><td align="left">25.3&#160;&#177;&#160;2.6</td><td align="left">27.0&#160;&#177;&#160;1.8</td><td align="left">NS</td></tr><tr><td align="left">Body height (cm)</td><td align="left">181.7&#160;&#177;&#160;6.8</td><td align="left">181.5&#160;&#177;&#160;6.1</td><td align="left">182.8&#160;&#177;&#160;7.7</td><td align="left">NS</td><td align="left">181.7&#160;&#177;&#160;6.8</td><td align="left">181.3&#160;&#177;&#160;5.6</td><td align="left">190.7&#160;&#177;&#160;6.3</td><td align="left">0.02</td></tr><tr><td align="left">Arm span (cm)</td><td align="left">183.4&#160;&#177;&#160;8.2 </td><td align="left">183.1&#160;&#177;&#160;7.0</td><td align="left">185.4&#160;&#177;&#160;8.9</td><td align="left">NS</td><td align="left">183.3&#160;&#177;&#160;8.0</td><td align="left">182.6&#160;&#177;&#160;6.9</td><td align="left">193.5&#160;&#177;&#160;6.8</td><td align="left">0.04</td></tr><tr><td align="left">Body weight (kg)</td><td align="left">81.9&#160;&#177;&#160;11.8</td><td align="left">81.1&#160;&#177;&#160;12.4</td><td align="left">85.9&#160;&#177;&#160;16.7</td><td align="left">NS</td><td align="left">81.7&#160;&#177;&#160;12.1</td><td align="left">82.2&#160;&#177;&#160;12.9</td><td align="left">90.4&#160;&#177;&#160;12.2</td><td align="left">NS</td></tr><tr><td align="left">Body mass index (kg/m<sup>2</sup>)</td><td align="left">24.8&#160;&#177;&#160;3.3</td><td align="left">24.6&#160;&#177;&#160;3.7</td><td align="left">25.6&#160;&#177;&#160;4.1</td><td align="left">NS</td><td align="left">24.8&#160;&#177;&#160;3.3</td><td align="left">25.1&#160;&#177;&#160;4.3</td><td align="left">24.8&#160;&#177;&#160;1.8</td><td align="left">NS</td></tr><tr><td align="left">Total fat mass (kg)</td><td align="left">14.9&#160;&#177;&#160;6.2</td><td align="left">14.9&#160;&#177;&#160;7.3</td><td align="left">17.7&#160;&#177;&#160;8.5</td><td align="left">NS</td><td align="left">15.3&#160;&#177;&#160;6.2</td><td align="left">15.1&#160;&#177;&#160;6.7</td><td align="left">17.9&#160;&#177;&#160;7.9</td><td align="left">NS</td></tr><tr><td align="left">Lean body mass (kg)</td><td align="left">64.0&#160;&#177;&#160;7.3</td><td align="left">63.3&#160;&#177;&#160;6.8</td><td align="left">65.3&#160;&#177;&#160;9.0</td><td align="left">NS</td><td align="left">64.7&#160;&#177;&#160;6.9 </td><td align="left">64.4&#160;&#177;&#160;6.0</td><td align="left">70.4&#160;&#177;&#160;7.0</td><td align="left">NS</td></tr><tr><td align="left">Units alcohol/week (<italic>n</italic>)</td><td align="left">11.4&#160;&#177;&#160;10.2</td><td align="left">10.7&#160;&#177;&#160;8.6</td><td align="left">12.3&#160;&#177;&#160;8.7</td><td align="left">NS</td><td align="left">11.0&#160;&#177;&#160;9.4</td><td align="left">10.8&#160;&#177;&#160;8.1</td><td align="left">6.5&#160;&#177;&#160;7.3</td><td align="left">NS</td></tr><tr><td align="left">Cigarettes/day (<italic>n</italic>)</td><td align="left">0 [0&#8211;45]</td><td align="left">0 [0&#8211;35]</td><td align="left">0 [0&#8211;25]</td><td align="left">NS</td><td align="left">0 [0&#8211;35]</td><td align="left">0 [0&#8211;30]</td><td align="left">0 [0&#8211;1]</td><td align="left">NS</td></tr><tr><td align="left">Serum 25-OH-D<sub>3</sub> (nmol/l)</td><td align="left">65.1&#160;&#177;&#160;27.9</td><td align="left">64.2&#160;&#177;&#160;26.9</td><td align="left">67.9&#160;&#177;&#160;28.6</td><td align="left">NS</td><td align="left">65.2&#160;&#177;&#160;27.5</td><td align="left">63.0&#160;&#177;&#160;29.1</td><td align="left">60.0&#160;&#177;&#160;25.4</td><td align="left">NS</td></tr><tr><td align="left">Serum IGF-I (&#956;g/l)</td><td align="left">199.9&#160;&#177;&#160;52.8</td><td align="left">202.4&#160;&#177;&#160;50.3</td><td align="left">191.0&#160;&#177;&#160;36.1</td><td align="left">NS</td><td align="left">27.6&#160;&#177;&#160;7.5</td><td align="left">25.5&#160;&#177;&#160;6.6</td><td align="left">27.3&#160;&#177;&#160;7.8</td><td align="left">NS</td></tr><tr><td align="left">Serum osteocalcin (mmol/l)</td><td align="left">3.0&#160;&#177;&#160;1.1</td><td align="left">3.1&#160;&#177;&#160;1.3</td><td align="left">3.0&#160;&#177;&#160;1.0</td><td align="left">NS</td><td align="left">3.1&#160;&#177;&#160;1.2</td><td align="left">2.8&#160;&#177;&#160;1.0</td><td align="left">2.3&#160;&#177;&#160;0.5</td><td align="left">NS</td></tr><tr><td align="left">Serum 1CTP (&#956;g/l)</td><td align="left">5.0&#160;&#177;&#160;1.4</td><td align="left">4.9&#160;&#177;&#160;1,5</td><td align="left">5.1&#160;&#177;&#160;1.3</td><td align="left">NS</td><td align="left">5.0&#160;&#177;&#160;1.4</td><td align="left">4.9&#160;&#177;&#160;1.4</td><td align="left">4.9&#160;&#177;&#160;0.9</td><td align="left">NS</td></tr><tr><td align="left">Bone-AP (U/l)</td><td align="left">26. 6&#160;&#177;&#160;8.1</td><td align="left">28.4&#160;&#177;&#160;10.0</td><td align="left">26.7&#160;&#177;&#160;8.3</td><td align="left">NS</td><td align="left">26.7&#160;&#177;&#160;8.2</td><td align="left">25.8&#160;&#177;&#160;7.0</td><td align="left">33.4&#160;&#177;&#160;16.4</td><td align="left">NS</td></tr><tr><td align="left">BMD<sub>spine</sub> (g/cm<sup>2</sup>)</td><td align="left">1.08&#160;&#177;&#160;0.12</td><td align="left">1.07&#160;&#177;&#160;0.17</td><td align="left">1.05&#160;&#177;&#160;0.13</td><td align="left">NS</td><td align="left">1.08&#160;&#177;&#160;0.12</td><td align="left">1.07&#160;&#177;&#160;0.22</td><td align="left">1.07&#160;&#177;&#160;0.15</td><td align="left">NS</td></tr><tr><td align="left">BMD<sub>hip</sub> (g/cm<sup>2</sup>)</td><td align="left">0.95&#160;&#177;&#160;0.14</td><td align="left">0.94&#160;&#177;&#160;0.14</td><td align="left">0.94&#160;&#177;&#160;0.15</td><td align="left">NS</td><td align="left">0.95&#160;&#177;&#160;0.14</td><td align="left">0.96&#160;&#177;&#160;0.15</td><td align="left">0.84&#160;&#177;&#160;0.07</td><td align="left">0.03</td></tr><tr><td align="left">BMD<sub>WB</sub> (g/cm<sup>2</sup>)</td><td align="left">1.22&#160;&#177;&#160;0.10*</td><td align="left">1.21&#160;&#177;&#160;0.09</td><td align="left">1.21&#160;&#177;&#160;0.11</td><td align="left">NS</td><td align="left">1.22&#160;&#177;&#160;0.10</td><td align="left">1.21&#160;&#177;&#160;0.11</td><td align="left">1.20&#160;&#177;&#160;0.08</td><td align="left">NS</td></tr><tr><td align="left">Sedentary/non-sedentary (<italic>n</italic>)</td><td align="left">150/440</td><td align="left">37/133</td><td align="left">4/16</td><td align="left">NS</td><td align="left">171/528</td><td align="left">18/58</td><td align="left">1/3</td><td align="left">NS</td></tr></tbody>
###xml 362 2132 362 1938 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left" colspan="8">Polymorphisms</th></tr><tr><th align="left"/><th align="left" colspan="4">Ala1330Val</th><th align="left" colspan="4">Val667Met</th></tr><tr><th align="left"/><th align="left">CC</th><th align="left">CT</th><th align="left">TT</th><th align="left"><italic>p</italic> values (ANOVA)</th><th align="left">GG</th><th align="left">GA</th><th align="left">AA</th><th align="left"><italic>p</italic> values (ANOVA)</th></tr></thead><tbody><tr><td align="left"><italic>n</italic></td><td align="left">589</td><td align="left">170</td><td align="left">20</td><td align="left">&#8211;</td><td align="left">699</td><td align="left">76</td><td align="left">4</td><td align="left">&#8211;</td></tr><tr><td align="left">Age (years)</td><td align="left">25.5&#160;&#177;&#160;2.8</td><td align="left">25.3&#160;&#177;&#160;2.8</td><td align="left">25.9&#160;&#177;&#160;2.7</td><td align="left">NS</td><td align="left">25.5&#160;&#177;&#160;2.8</td><td align="left">25.3&#160;&#177;&#160;2.6</td><td align="left">27.0&#160;&#177;&#160;1.8</td><td align="left">NS</td></tr><tr><td align="left">Body height (cm)</td><td align="left">181.7&#160;&#177;&#160;6.8</td><td align="left">181.5&#160;&#177;&#160;6.1</td><td align="left">182.8&#160;&#177;&#160;7.7</td><td align="left">NS</td><td align="left">181.7&#160;&#177;&#160;6.8</td><td align="left">181.3&#160;&#177;&#160;5.6</td><td align="left">190.7&#160;&#177;&#160;6.3</td><td align="left">0.02</td></tr><tr><td align="left">Arm span (cm)</td><td align="left">183.4&#160;&#177;&#160;8.2 </td><td align="left">183.1&#160;&#177;&#160;7.0</td><td align="left">185.4&#160;&#177;&#160;8.9</td><td align="left">NS</td><td align="left">183.3&#160;&#177;&#160;8.0</td><td align="left">182.6&#160;&#177;&#160;6.9</td><td align="left">193.5&#160;&#177;&#160;6.8</td><td align="left">0.04</td></tr><tr><td align="left">Body weight (kg)</td><td align="left">81.9&#160;&#177;&#160;11.8</td><td align="left">81.1&#160;&#177;&#160;12.4</td><td align="left">85.9&#160;&#177;&#160;16.7</td><td align="left">NS</td><td align="left">81.7&#160;&#177;&#160;12.1</td><td align="left">82.2&#160;&#177;&#160;12.9</td><td align="left">90.4&#160;&#177;&#160;12.2</td><td align="left">NS</td></tr><tr><td align="left">Body mass index (kg/m<sup>2</sup>)</td><td align="left">24.8&#160;&#177;&#160;3.3</td><td align="left">24.6&#160;&#177;&#160;3.7</td><td align="left">25.6&#160;&#177;&#160;4.1</td><td align="left">NS</td><td align="left">24.8&#160;&#177;&#160;3.3</td><td align="left">25.1&#160;&#177;&#160;4.3</td><td align="left">24.8&#160;&#177;&#160;1.8</td><td align="left">NS</td></tr><tr><td align="left">Total fat mass (kg)</td><td align="left">14.9&#160;&#177;&#160;6.2</td><td align="left">14.9&#160;&#177;&#160;7.3</td><td align="left">17.7&#160;&#177;&#160;8.5</td><td align="left">NS</td><td align="left">15.3&#160;&#177;&#160;6.2</td><td align="left">15.1&#160;&#177;&#160;6.7</td><td align="left">17.9&#160;&#177;&#160;7.9</td><td align="left">NS</td></tr><tr><td align="left">Lean body mass (kg)</td><td align="left">64.0&#160;&#177;&#160;7.3</td><td align="left">63.3&#160;&#177;&#160;6.8</td><td align="left">65.3&#160;&#177;&#160;9.0</td><td align="left">NS</td><td align="left">64.7&#160;&#177;&#160;6.9 </td><td align="left">64.4&#160;&#177;&#160;6.0</td><td align="left">70.4&#160;&#177;&#160;7.0</td><td align="left">NS</td></tr><tr><td align="left">Units alcohol/week (<italic>n</italic>)</td><td align="left">11.4&#160;&#177;&#160;10.2</td><td align="left">10.7&#160;&#177;&#160;8.6</td><td align="left">12.3&#160;&#177;&#160;8.7</td><td align="left">NS</td><td align="left">11.0&#160;&#177;&#160;9.4</td><td align="left">10.8&#160;&#177;&#160;8.1</td><td align="left">6.5&#160;&#177;&#160;7.3</td><td align="left">NS</td></tr><tr><td align="left">Cigarettes/day (<italic>n</italic>)</td><td align="left">0 [0&#8211;45]</td><td align="left">0 [0&#8211;35]</td><td align="left">0 [0&#8211;25]</td><td align="left">NS</td><td align="left">0 [0&#8211;35]</td><td align="left">0 [0&#8211;30]</td><td align="left">0 [0&#8211;1]</td><td align="left">NS</td></tr><tr><td align="left">Serum 25-OH-D<sub>3</sub> (nmol/l)</td><td align="left">65.1&#160;&#177;&#160;27.9</td><td align="left">64.2&#160;&#177;&#160;26.9</td><td align="left">67.9&#160;&#177;&#160;28.6</td><td align="left">NS</td><td align="left">65.2&#160;&#177;&#160;27.5</td><td align="left">63.0&#160;&#177;&#160;29.1</td><td align="left">60.0&#160;&#177;&#160;25.4</td><td align="left">NS</td></tr><tr><td align="left">Serum IGF-I (&#956;g/l)</td><td align="left">199.9&#160;&#177;&#160;52.8</td><td align="left">202.4&#160;&#177;&#160;50.3</td><td align="left">191.0&#160;&#177;&#160;36.1</td><td align="left">NS</td><td align="left">27.6&#160;&#177;&#160;7.5</td><td align="left">25.5&#160;&#177;&#160;6.6</td><td align="left">27.3&#160;&#177;&#160;7.8</td><td align="left">NS</td></tr><tr><td align="left">Serum osteocalcin (mmol/l)</td><td align="left">3.0&#160;&#177;&#160;1.1</td><td align="left">3.1&#160;&#177;&#160;1.3</td><td align="left">3.0&#160;&#177;&#160;1.0</td><td align="left">NS</td><td align="left">3.1&#160;&#177;&#160;1.2</td><td align="left">2.8&#160;&#177;&#160;1.0</td><td align="left">2.3&#160;&#177;&#160;0.5</td><td align="left">NS</td></tr><tr><td align="left">Serum 1CTP (&#956;g/l)</td><td align="left">5.0&#160;&#177;&#160;1.4</td><td align="left">4.9&#160;&#177;&#160;1,5</td><td align="left">5.1&#160;&#177;&#160;1.3</td><td align="left">NS</td><td align="left">5.0&#160;&#177;&#160;1.4</td><td align="left">4.9&#160;&#177;&#160;1.4</td><td align="left">4.9&#160;&#177;&#160;0.9</td><td align="left">NS</td></tr><tr><td align="left">Bone-AP (U/l)</td><td align="left">26. 6&#160;&#177;&#160;8.1</td><td align="left">28.4&#160;&#177;&#160;10.0</td><td align="left">26.7&#160;&#177;&#160;8.3</td><td align="left">NS</td><td align="left">26.7&#160;&#177;&#160;8.2</td><td align="left">25.8&#160;&#177;&#160;7.0</td><td align="left">33.4&#160;&#177;&#160;16.4</td><td align="left">NS</td></tr><tr><td align="left">BMD<sub>spine</sub> (g/cm<sup>2</sup>)</td><td align="left">1.08&#160;&#177;&#160;0.12</td><td align="left">1.07&#160;&#177;&#160;0.17</td><td align="left">1.05&#160;&#177;&#160;0.13</td><td align="left">NS</td><td align="left">1.08&#160;&#177;&#160;0.12</td><td align="left">1.07&#160;&#177;&#160;0.22</td><td align="left">1.07&#160;&#177;&#160;0.15</td><td align="left">NS</td></tr><tr><td align="left">BMD<sub>hip</sub> (g/cm<sup>2</sup>)</td><td align="left">0.95&#160;&#177;&#160;0.14</td><td align="left">0.94&#160;&#177;&#160;0.14</td><td align="left">0.94&#160;&#177;&#160;0.15</td><td align="left">NS</td><td align="left">0.95&#160;&#177;&#160;0.14</td><td align="left">0.96&#160;&#177;&#160;0.15</td><td align="left">0.84&#160;&#177;&#160;0.07</td><td align="left">0.03</td></tr><tr><td align="left">BMD<sub>WB</sub> (g/cm<sup>2</sup>)</td><td align="left">1.22&#160;&#177;&#160;0.10*</td><td align="left">1.21&#160;&#177;&#160;0.09</td><td align="left">1.21&#160;&#177;&#160;0.11</td><td align="left">NS</td><td align="left">1.22&#160;&#177;&#160;0.10</td><td align="left">1.21&#160;&#177;&#160;0.11</td><td align="left">1.20&#160;&#177;&#160;0.08</td><td align="left">NS</td></tr><tr><td align="left">Sedentary/non-sedentary (<italic>n</italic>)</td><td align="left">150/440</td><td align="left">37/133</td><td align="left">4/16</td><td align="left">NS</td><td align="left">171/528</td><td align="left">18/58</td><td align="left">1/3</td><td align="left">NS</td></tr></tbody></table>
###xml 2257 2258 2063 2064 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 2327 2328 2131 2132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 2336 2337 2140 2141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2360 2361 2162 2163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 2370 2371 2172 2173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2132 2379 1938 2181 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="39">No significant differences were found between the groups (ANOVA). This was true also if the CT and TT genotypes were pooled (<italic>t</italic>-test). Genotypes were in Hardy-Weinberg equilibrium (Ala1330Val: &#967;<sup>2</sup>&#160;=&#160;3.2, <italic>p</italic>&#160;=&#160;0.07; Val667Met: &#967;<sup>2</sup>&#160;=&#160;1.48, <italic>p</italic>&#160;=&#160;0.22)</p>
###xml 2380 2381 2182 2183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2379 2455 2181 2257 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="40">*<italic>p</italic>&#160;=&#160;0.05 comparing the CC genotype with CT&#160;+&#160;TT pooled; NS, not significant</p>
###xml 2132 2455 1938 2257 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="39">No significant differences were found between the groups (ANOVA). This was true also if the CT and TT genotypes were pooled (<italic>t</italic>-test). Genotypes were in Hardy-Weinberg equilibrium (Ala1330Val: &#967;<sup>2</sup>&#160;=&#160;3.2, <italic>p</italic>&#160;=&#160;0.07; Val667Met: &#967;<sup>2</sup>&#160;=&#160;1.48, <italic>p</italic>&#160;=&#160;0.22)</p><p textid="40">*<italic>p</italic>&#160;=&#160;0.05 comparing the CC genotype with CT&#160;+&#160;TT pooled; NS, not significant</p></table-wrap-foot>
###xml 240 2455 240 2257 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="38">Covariates, BMD, and lifestyle (sedentary/non-sedentary) by LRP5 genotypes (Ala1330Val and Val667Met polymorphisms)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left" colspan="8">Polymorphisms</th></tr><tr><th align="left"/><th align="left" colspan="4">Ala1330Val</th><th align="left" colspan="4">Val667Met</th></tr><tr><th align="left"/><th align="left">CC</th><th align="left">CT</th><th align="left">TT</th><th align="left"><italic>p</italic> values (ANOVA)</th><th align="left">GG</th><th align="left">GA</th><th align="left">AA</th><th align="left"><italic>p</italic> values (ANOVA)</th></tr></thead><tbody><tr><td align="left"><italic>n</italic></td><td align="left">589</td><td align="left">170</td><td align="left">20</td><td align="left">&#8211;</td><td align="left">699</td><td align="left">76</td><td align="left">4</td><td align="left">&#8211;</td></tr><tr><td align="left">Age (years)</td><td align="left">25.5&#160;&#177;&#160;2.8</td><td align="left">25.3&#160;&#177;&#160;2.8</td><td align="left">25.9&#160;&#177;&#160;2.7</td><td align="left">NS</td><td align="left">25.5&#160;&#177;&#160;2.8</td><td align="left">25.3&#160;&#177;&#160;2.6</td><td align="left">27.0&#160;&#177;&#160;1.8</td><td align="left">NS</td></tr><tr><td align="left">Body height (cm)</td><td align="left">181.7&#160;&#177;&#160;6.8</td><td align="left">181.5&#160;&#177;&#160;6.1</td><td align="left">182.8&#160;&#177;&#160;7.7</td><td align="left">NS</td><td align="left">181.7&#160;&#177;&#160;6.8</td><td align="left">181.3&#160;&#177;&#160;5.6</td><td align="left">190.7&#160;&#177;&#160;6.3</td><td align="left">0.02</td></tr><tr><td align="left">Arm span (cm)</td><td align="left">183.4&#160;&#177;&#160;8.2 </td><td align="left">183.1&#160;&#177;&#160;7.0</td><td align="left">185.4&#160;&#177;&#160;8.9</td><td align="left">NS</td><td align="left">183.3&#160;&#177;&#160;8.0</td><td align="left">182.6&#160;&#177;&#160;6.9</td><td align="left">193.5&#160;&#177;&#160;6.8</td><td align="left">0.04</td></tr><tr><td align="left">Body weight (kg)</td><td align="left">81.9&#160;&#177;&#160;11.8</td><td align="left">81.1&#160;&#177;&#160;12.4</td><td align="left">85.9&#160;&#177;&#160;16.7</td><td align="left">NS</td><td align="left">81.7&#160;&#177;&#160;12.1</td><td align="left">82.2&#160;&#177;&#160;12.9</td><td align="left">90.4&#160;&#177;&#160;12.2</td><td align="left">NS</td></tr><tr><td align="left">Body mass index (kg/m<sup>2</sup>)</td><td align="left">24.8&#160;&#177;&#160;3.3</td><td align="left">24.6&#160;&#177;&#160;3.7</td><td align="left">25.6&#160;&#177;&#160;4.1</td><td align="left">NS</td><td align="left">24.8&#160;&#177;&#160;3.3</td><td align="left">25.1&#160;&#177;&#160;4.3</td><td align="left">24.8&#160;&#177;&#160;1.8</td><td align="left">NS</td></tr><tr><td align="left">Total fat mass (kg)</td><td align="left">14.9&#160;&#177;&#160;6.2</td><td align="left">14.9&#160;&#177;&#160;7.3</td><td align="left">17.7&#160;&#177;&#160;8.5</td><td align="left">NS</td><td align="left">15.3&#160;&#177;&#160;6.2</td><td align="left">15.1&#160;&#177;&#160;6.7</td><td align="left">17.9&#160;&#177;&#160;7.9</td><td align="left">NS</td></tr><tr><td align="left">Lean body mass (kg)</td><td align="left">64.0&#160;&#177;&#160;7.3</td><td align="left">63.3&#160;&#177;&#160;6.8</td><td align="left">65.3&#160;&#177;&#160;9.0</td><td align="left">NS</td><td align="left">64.7&#160;&#177;&#160;6.9 </td><td align="left">64.4&#160;&#177;&#160;6.0</td><td align="left">70.4&#160;&#177;&#160;7.0</td><td align="left">NS</td></tr><tr><td align="left">Units alcohol/week (<italic>n</italic>)</td><td align="left">11.4&#160;&#177;&#160;10.2</td><td align="left">10.7&#160;&#177;&#160;8.6</td><td align="left">12.3&#160;&#177;&#160;8.7</td><td align="left">NS</td><td align="left">11.0&#160;&#177;&#160;9.4</td><td align="left">10.8&#160;&#177;&#160;8.1</td><td align="left">6.5&#160;&#177;&#160;7.3</td><td align="left">NS</td></tr><tr><td align="left">Cigarettes/day (<italic>n</italic>)</td><td align="left">0 [0&#8211;45]</td><td align="left">0 [0&#8211;35]</td><td align="left">0 [0&#8211;25]</td><td align="left">NS</td><td align="left">0 [0&#8211;35]</td><td align="left">0 [0&#8211;30]</td><td align="left">0 [0&#8211;1]</td><td align="left">NS</td></tr><tr><td align="left">Serum 25-OH-D<sub>3</sub> (nmol/l)</td><td align="left">65.1&#160;&#177;&#160;27.9</td><td align="left">64.2&#160;&#177;&#160;26.9</td><td align="left">67.9&#160;&#177;&#160;28.6</td><td align="left">NS</td><td align="left">65.2&#160;&#177;&#160;27.5</td><td align="left">63.0&#160;&#177;&#160;29.1</td><td align="left">60.0&#160;&#177;&#160;25.4</td><td align="left">NS</td></tr><tr><td align="left">Serum IGF-I (&#956;g/l)</td><td align="left">199.9&#160;&#177;&#160;52.8</td><td align="left">202.4&#160;&#177;&#160;50.3</td><td align="left">191.0&#160;&#177;&#160;36.1</td><td align="left">NS</td><td align="left">27.6&#160;&#177;&#160;7.5</td><td align="left">25.5&#160;&#177;&#160;6.6</td><td align="left">27.3&#160;&#177;&#160;7.8</td><td align="left">NS</td></tr><tr><td align="left">Serum osteocalcin (mmol/l)</td><td align="left">3.0&#160;&#177;&#160;1.1</td><td align="left">3.1&#160;&#177;&#160;1.3</td><td align="left">3.0&#160;&#177;&#160;1.0</td><td align="left">NS</td><td align="left">3.1&#160;&#177;&#160;1.2</td><td align="left">2.8&#160;&#177;&#160;1.0</td><td align="left">2.3&#160;&#177;&#160;0.5</td><td align="left">NS</td></tr><tr><td align="left">Serum 1CTP (&#956;g/l)</td><td align="left">5.0&#160;&#177;&#160;1.4</td><td align="left">4.9&#160;&#177;&#160;1,5</td><td align="left">5.1&#160;&#177;&#160;1.3</td><td align="left">NS</td><td align="left">5.0&#160;&#177;&#160;1.4</td><td align="left">4.9&#160;&#177;&#160;1.4</td><td align="left">4.9&#160;&#177;&#160;0.9</td><td align="left">NS</td></tr><tr><td align="left">Bone-AP (U/l)</td><td align="left">26. 6&#160;&#177;&#160;8.1</td><td align="left">28.4&#160;&#177;&#160;10.0</td><td align="left">26.7&#160;&#177;&#160;8.3</td><td align="left">NS</td><td align="left">26.7&#160;&#177;&#160;8.2</td><td align="left">25.8&#160;&#177;&#160;7.0</td><td align="left">33.4&#160;&#177;&#160;16.4</td><td align="left">NS</td></tr><tr><td align="left">BMD<sub>spine</sub> (g/cm<sup>2</sup>)</td><td align="left">1.08&#160;&#177;&#160;0.12</td><td align="left">1.07&#160;&#177;&#160;0.17</td><td align="left">1.05&#160;&#177;&#160;0.13</td><td align="left">NS</td><td align="left">1.08&#160;&#177;&#160;0.12</td><td align="left">1.07&#160;&#177;&#160;0.22</td><td align="left">1.07&#160;&#177;&#160;0.15</td><td align="left">NS</td></tr><tr><td align="left">BMD<sub>hip</sub> (g/cm<sup>2</sup>)</td><td align="left">0.95&#160;&#177;&#160;0.14</td><td align="left">0.94&#160;&#177;&#160;0.14</td><td align="left">0.94&#160;&#177;&#160;0.15</td><td align="left">NS</td><td align="left">0.95&#160;&#177;&#160;0.14</td><td align="left">0.96&#160;&#177;&#160;0.15</td><td align="left">0.84&#160;&#177;&#160;0.07</td><td align="left">0.03</td></tr><tr><td align="left">BMD<sub>WB</sub> (g/cm<sup>2</sup>)</td><td align="left">1.22&#160;&#177;&#160;0.10*</td><td align="left">1.21&#160;&#177;&#160;0.09</td><td align="left">1.21&#160;&#177;&#160;0.11</td><td align="left">NS</td><td align="left">1.22&#160;&#177;&#160;0.10</td><td align="left">1.21&#160;&#177;&#160;0.11</td><td align="left">1.20&#160;&#177;&#160;0.08</td><td align="left">NS</td></tr><tr><td align="left">Sedentary/non-sedentary (<italic>n</italic>)</td><td align="left">150/440</td><td align="left">37/133</td><td align="left">4/16</td><td align="left">NS</td><td align="left">171/528</td><td align="left">18/58</td><td align="left">1/3</td><td align="left">NS</td></tr></tbody></table><table-wrap-foot><p textid="39">No significant differences were found between the groups (ANOVA). This was true also if the CT and TT genotypes were pooled (<italic>t</italic>-test). Genotypes were in Hardy-Weinberg equilibrium (Ala1330Val: &#967;<sup>2</sup>&#160;=&#160;3.2, <italic>p</italic>&#160;=&#160;0.07; Val667Met: &#967;<sup>2</sup>&#160;=&#160;1.48, <italic>p</italic>&#160;=&#160;0.22)</p><p textid="40">*<italic>p</italic>&#160;=&#160;0.05 comparing the CC genotype with CT&#160;+&#160;TT pooled; NS, not significant</p></table-wrap-foot></table-wrap>
For the Ala1330Val polymorphism, the CC genotype was found in 589 (75.6%), the CT genotype in 170 (21.8%), and the TT genotype in 20 (2.6%), respectively (Table 1) allele frequencies of 0.87 and 0.13 for the C- and T-alleles, respectively. Table 1Covariates, BMD, and lifestyle (sedentary/non-sedentary) by LRP5 genotypes (Ala1330Val and Val667Met polymorphisms)PolymorphismsAla1330ValVal667MetCCCTTTp values (ANOVA)GGGAAAp values (ANOVA)n58917020-699764-Age (years)25.5 +/- 2.825.3 +/- 2.825.9 +/- 2.7NS25.5 +/- 2.825.3 +/- 2.627.0 +/- 1.8NSBody height (cm)181.7 +/- 6.8181.5 +/- 6.1182.8 +/- 7.7NS181.7 +/- 6.8181.3 +/- 5.6190.7 +/- 6.30.02Arm span (cm)183.4 +/- 8.2 183.1 +/- 7.0185.4 +/- 8.9NS183.3 +/- 8.0182.6 +/- 6.9193.5 +/- 6.80.04Body weight (kg)81.9 +/- 11.881.1 +/- 12.485.9 +/- 16.7NS81.7 +/- 12.182.2 +/- 12.990.4 +/- 12.2NSBody mass index (kg/m2)24.8 +/- 3.324.6 +/- 3.725.6 +/- 4.1NS24.8 +/- 3.325.1 +/- 4.324.8 +/- 1.8NSTotal fat mass (kg)14.9 +/- 6.214.9 +/- 7.317.7 +/- 8.5NS15.3 +/- 6.215.1 +/- 6.717.9 +/- 7.9NSLean body mass (kg)64.0 +/- 7.363.3 +/- 6.865.3 +/- 9.0NS64.7 +/- 6.9 64.4 +/- 6.070.4 +/- 7.0NSUnits alcohol/week (n)11.4 +/- 10.210.7 +/- 8.612.3 +/- 8.7NS11.0 +/- 9.410.8 +/- 8.16.5 +/- 7.3NSCigarettes/day (n)0 [0-45]0 [0-35]0 [0-25]NS0 [0-35]0 [0-30]0 [0-1]NSSerum 25-OH-D3 (nmol/l)65.1 +/- 27.964.2 +/- 26.967.9 +/- 28.6NS65.2 +/- 27.563.0 +/- 29.160.0 +/- 25.4NSSerum IGF-I (mug/l)199.9 +/- 52.8202.4 +/- 50.3191.0 +/- 36.1NS27.6 +/- 7.525.5 +/- 6.627.3 +/- 7.8NSSerum osteocalcin (mmol/l)3.0 +/- 1.13.1 +/- 1.33.0 +/- 1.0NS3.1 +/- 1.22.8 +/- 1.02.3 +/- 0.5NSSerum 1CTP (mug/l)5.0 +/- 1.44.9 +/- 1,55.1 +/- 1.3NS5.0 +/- 1.44.9 +/- 1.44.9 +/- 0.9NSBone-AP (U/l)26. 6 +/- 8.128.4 +/- 10.026.7 +/- 8.3NS26.7 +/- 8.225.8 +/- 7.033.4 +/- 16.4NSBMDspine (g/cm2)1.08 +/- 0.121.07 +/- 0.171.05 +/- 0.13NS1.08 +/- 0.121.07 +/- 0.221.07 +/- 0.15NSBMDhip (g/cm2)0.95 +/- 0.140.94 +/- 0.140.94 +/- 0.15NS0.95 +/- 0.140.96 +/- 0.150.84 +/- 0.070.03BMDWB (g/cm2)1.22 +/- 0.10*1.21 +/- 0.091.21 +/- 0.11NS1.22 +/- 0.101.21 +/- 0.111.20 +/- 0.08NSSedentary/non-sedentary (n)150/44037/1334/16NS171/52818/581/3NSNo significant differences were found between the groups (ANOVA). This was true also if the CT and TT genotypes were pooled (t-test). Genotypes were in Hardy-Weinberg equilibrium (Ala1330Val: chi2 = 3.2, p = 0.07; Val667Met: chi2 = 1.48, p = 0.22)*p = 0.05 comparing the CC genotype with CT + TT pooled; NS, not significant
###end p 37
###begin p 38
Covariates, BMD, and lifestyle (sedentary/non-sedentary) by LRP5 genotypes (Ala1330Val and Val667Met polymorphisms)
###end p 38
###begin p 39
###xml 125 126 125 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 195 196 193 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 204 205 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 228 229 224 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 238 239 234 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
No significant differences were found between the groups (ANOVA). This was true also if the CT and TT genotypes were pooled (t-test). Genotypes were in Hardy-Weinberg equilibrium (Ala1330Val: chi2 = 3.2, p = 0.07; Val667Met: chi2 = 1.48, p = 0.22)
###end p 39
###begin p 40
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
*p = 0.05 comparing the CC genotype with CT + TT pooled; NS, not significant
###end p 40
###begin p 41
Similarly, the GG, GA, AA genotypes of the Val667Met polymorphism were found in 699 (89.7%), 76 (9.8%), and 4 (0.5%), respectively. This corresponds to allele frequencies of 0.95 and 0.05 for the G- and A-alleles, respectively.
###end p 41
###begin p 42
###xml 78 79 76 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 87 88 85 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 103 104 99 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 113 114 109 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 191 192 187 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 203 204 199 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
Both allele distributions were compatible with Hardy-Weinberg equilibrium (chi2 = 3.2, p = 0.07 and chi2 = 1.48, p = 0.22). The two polymorphisms were not in complete linkage disequilibrium (D' = 0.955, R(2) = 0.33).
###end p 42
###begin title 43
Covariates
###end title 43
###begin p 44
###xml 63 64 63 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 254 255 254 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 500 501 494 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 578 579 566 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Data on covariates in relation to genotypes are shown in Table 1. No significant differences regarding covariates (age, body height, body weight, BMI, sitting height (not shown), total fat mass, lean body mass, alcohol consumption, smoking, serum 25-OH-D3, or serum IGF-I) were seen between the genotypes of the two polymorphisms. Regarding the Val667Met genotypes, however, subjects with the AA genotype had significantly increased body height (190.7 +/- 6.6 vs. 181.7 +/- 6.8 and 181.3 +/- 5.6 cm, p = 0.02) and arm span (193.5 +/- 6.8 vs. 183.3 +/- 8.0 and 182.6 +/- 6.9 cm, p = 0.04).
###end p 44
###begin title 45
BMD in Relation to Age
###end title 45
###begin p 46
###xml 202 203 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
In the spine, no relationship between BMD and age could be detected. Maximum BMD in the total hip was observed around the age of 22 years. In subjects above this age BMD was significantly lower (ANOVA, p < 0.05). In subjects aged 30 years, BMD was 5.5% lower that the observed maximum.
###end p 46
###begin title 47
Genotypes in Relation to BMD
###end title 47
###begin p 48
###xml 334 335 330 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Regarding the Ala1330Val polymorphism, no significant differences between BMD in the spine, hip, or whole body were found between subjects with the CC, CT, and TT genotypes. When the CT and TT genotypes were pooled, whole-body BMD was significantly lower in the CT + TT compared with the CC genotype (1.21 +/- 0.10 vs. 1.22 +/- 0.10, p = 0.05).
###end p 48
###begin p 49
Regarding the Val 667Met polymorphism, a significant difference in hip BMD was observed, since subjects with the AA genotype had lower BMD (0.84 +/- 0.07 vs. 0.95 +/- 0.14 and 0.96 +/- 0.15, p = 0.03).
###end p 49
###begin p 50
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
Table 1 also shows the distribution of genotypes in relation to sedentary/non-sedentary lifestyle, but no significant difference in lifestyle was found between any of the genotypes.
###end p 50
###begin p 51
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 261 262 261 262 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 432 433 432 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 475 476 475 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 706 713 706 713 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 713 815 713 815 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="52">Multiple regression analysis determining the change in BMD Z-score for each copy of the T- or A-allele</p>
###xml 713 815 713 815 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="52">Multiple regression analysis determining the change in BMD Z-score for each copy of the T- or A-allele</p></caption>
###xml 815 815 815 815 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2"/>
###xml 815 827 815 827 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="4">Polymorphism</th>
###xml 815 827 815 827 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" rowspan="2"/><th align="left" colspan="4">Polymorphism</th></tr>
###xml 827 837 827 837 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">Ala1330Val</th>
###xml 837 846 837 846 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">Val667Met</th>
###xml 827 846 827 846 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" colspan="2">Ala1330Val</th><th align="left" colspan="2">Val667Met</th></tr>
###xml 846 853 846 853 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Z-score</th>
###xml 853 863 853 863 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Unadjusted</th>
###xml 871 872 871 872 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 863 872 863 872 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Adjusted<sup>a</sup></th>
###xml 872 882 872 882 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Unadjusted</th>
###xml 890 891 890 891 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 882 891 882 891 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Adjusted<sup>a</sup></th>
###xml 846 891 846 891 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Z-score</th><th align="left">Unadjusted</th><th align="left">Adjusted<sup>a</sup></th><th align="left">Unadjusted</th><th align="left">Adjusted<sup>a</sup></th></tr>
###xml 815 891 815 891 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left" rowspan="2"/><th align="left" colspan="4">Polymorphism</th></tr><tr><th align="left" colspan="2">Ala1330Val</th><th align="left" colspan="2">Val667Met</th></tr><tr><th align="left">Z-score</th><th align="left">Unadjusted</th><th align="left">Adjusted<sup>a</sup></th><th align="left">Unadjusted</th><th align="left">Adjusted<sup>a</sup></th></tr></thead>
###xml 891 909 891 909 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Total population (</bold>
###xml 909 910 909 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 909 910 909 910 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>n</italic></bold>
###xml 910 917 910 917 <bold xmlns:xlink="http://www.w3.org/1999/xlink">&#160;=&#160;779)</bold>
###xml 891 917 891 917 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="5"><bold>Total population (</bold><bold><italic>n</italic></bold><bold>&#160;=&#160;779)</bold></td>
###xml 891 917 891 917 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="5"><bold>Total population (</bold><bold><italic>n</italic></bold><bold>&#160;=&#160;779)</bold></td></tr>
###xml 920 925 920 925 <sub xmlns:xlink="http://www.w3.org/1999/xlink">spine</sub>
###xml 917 925 917 925 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">BMD<sub>spine</sub></td>
###xml 944 946 944 946 <sup xmlns:xlink="http://www.w3.org/1999/xlink">NS</sup>
###xml 925 946 925 946 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.11 (&#8722;0.29; 0.06)<sup>NS</sup></td>
###xml 965 967 965 967 <sup xmlns:xlink="http://www.w3.org/1999/xlink">NS</sup>
###xml 946 967 946 967 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.10 (&#8722;0.27; 0.06)<sup>NS</sup></td>
###xml 987 989 987 989 <sup xmlns:xlink="http://www.w3.org/1999/xlink">NS</sup>
###xml 967 989 967 989 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.044 (&#8722;0.28; 0.19)<sup>NS</sup></td>
###xml 1009 1011 1009 1011 <sup xmlns:xlink="http://www.w3.org/1999/xlink">NS</sup>
###xml 989 1011 989 1011 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.054 (&#8722;0.27; 0.16)<sup>NS</sup></td>
###xml 917 1011 917 1011 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">BMD<sub>spine</sub></td><td char="." align="char">&#8722;0.11 (&#8722;0.29; 0.06)<sup>NS</sup></td><td char="." align="char">&#8722;0.10 (&#8722;0.27; 0.06)<sup>NS</sup></td><td char="." align="char">&#8722;0.044 (&#8722;0.28; 0.19)<sup>NS</sup></td><td char="." align="char">&#8722;0.054 (&#8722;0.27; 0.16)<sup>NS</sup></td></tr>
###xml 1014 1017 1014 1017 <sub xmlns:xlink="http://www.w3.org/1999/xlink">hip</sub>
###xml 1011 1017 1011 1017 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">BMD<sub>hip</sub></td>
###xml 1036 1038 1036 1038 <sup xmlns:xlink="http://www.w3.org/1999/xlink">NS</sup>
###xml 1017 1038 1017 1038 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.03 (&#8722;0.20; 0.11)<sup>NS</sup></td>
###xml 1057 1059 1057 1059 <sup xmlns:xlink="http://www.w3.org/1999/xlink">NS</sup>
###xml 1038 1059 1038 1059 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.02 (&#8722;0.17; 0.11)<sup>NS</sup></td>
###xml 1078 1080 1078 1080 <sup xmlns:xlink="http://www.w3.org/1999/xlink">NS</sup>
###xml 1059 1080 1059 1080 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.018 (&#8722;0.20; 0.23)<sup>NS</sup></td>
###xml 1099 1101 1099 1101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">NS</sup>
###xml 1080 1101 1080 1101 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.002 (&#8722;0.22; 0.21)<sup>NS</sup></td>
###xml 1011 1101 1011 1101 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">BMD<sub>hip</sub></td><td char="." align="char">&#8722;0.03 (&#8722;0.20; 0.11)<sup>NS</sup></td><td char="." align="char">&#8722;0.02 (&#8722;0.17; 0.11)<sup>NS</sup></td><td char="." align="char">0.018 (&#8722;0.20; 0.23)<sup>NS</sup></td><td char="." align="char">0.002 (&#8722;0.22; 0.21)<sup>NS</sup></td></tr>
###xml 1104 1106 1104 1106 <sub xmlns:xlink="http://www.w3.org/1999/xlink">WB</sub>
###xml 1101 1106 1101 1106 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">BMD<sub>WB</sub></td>
###xml 1125 1126 1125 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1125 1133 1125 1133 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>p</italic>&#160;=&#160;0.07</sup>
###xml 1106 1133 1106 1133 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.13 (&#8722;0.27; 0.11)<sup><italic>p</italic>&#160;=&#160;0.07</sup></td>
###xml 1152 1153 1152 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1152 1160 1152 1160 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>p</italic>&#160;=&#160;0.07</sup>
###xml 1133 1160 1133 1160 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.12 (&#8722;0.25; 0.01)<sup><italic>p</italic>&#160;=&#160;0.07</sup></td>
###xml 1180 1182 1180 1182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">NS</sup>
###xml 1160 1182 1160 1182 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.085 (&#8722;0.30; 0.13)<sup>NS</sup></td>
###xml 1201 1203 1201 1203 <sup xmlns:xlink="http://www.w3.org/1999/xlink">NS</sup>
###xml 1182 1203 1182 1203 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.11 (&#8722;0.33; 0.10)<sup>NS</sup></td>
###xml 1101 1203 1101 1203 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">BMD<sub>WB</sub></td><td char="." align="char">&#8722;0.13 (&#8722;0.27; 0.11)<sup><italic>p</italic>&#160;=&#160;0.07</sup></td><td char="." align="char">&#8722;0.12 (&#8722;0.25; 0.01)<sup><italic>p</italic>&#160;=&#160;0.07</sup></td><td char="." align="char">&#8722;0.085 (&#8722;0.30; 0.13)<sup>NS</sup></td><td char="." align="char">&#8722;0.11 (&#8722;0.33; 0.10)<sup>NS</sup></td></tr>
###xml 1203 1218 1203 1218 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Non-sedentary (</bold>
###xml 1218 1219 1218 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1218 1219 1218 1219 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>n</italic></bold>
###xml 1219 1226 1219 1226 <bold xmlns:xlink="http://www.w3.org/1999/xlink">&#160;=&#160;589)</bold>
###xml 1203 1226 1203 1226 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="5"><bold>Non-sedentary (</bold><bold><italic>n</italic></bold><bold>&#160;=&#160;589)</bold></td>
###xml 1203 1226 1203 1226 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="5"><bold>Non-sedentary (</bold><bold><italic>n</italic></bold><bold>&#160;=&#160;589)</bold></td></tr>
###xml 1229 1234 1229 1234 <sub xmlns:xlink="http://www.w3.org/1999/xlink">spine</sub>
###xml 1226 1234 1226 1234 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">BMD<sub>spine</sub></td>
###xml 1254 1255 1254 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1254 1262 1254 1262 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>p</italic>&#160;=&#160;0.02</sup>
###xml 1234 1262 1234 1262 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.21 (&#8722;0.40; &#8722;0.03)<sup><italic>p</italic>&#160;=&#160;0.02</sup></td>
###xml 1282 1283 1282 1283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1282 1290 1282 1290 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>p</italic>&#160;=&#160;0.01</sup>
###xml 1262 1290 1262 1290 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.20 (&#8722;0.37; &#8722;0.02)<sup><italic>p</italic>&#160;=&#160;0.01</sup></td>
###xml 1310 1311 1310 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1310 1318 1310 1318 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>p</italic>&#160;=&#160;0.04</sup>
###xml 1290 1318 1290 1318 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.26 (&#8722;0.51; &#8722;0.01)<sup><italic>p</italic>&#160;=&#160;0.04</sup></td>
###xml 1339 1340 1339 1340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1339 1348 1339 1348 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>p</italic>&#160;=&#160;0.048</sup>
###xml 1318 1348 1318 1348 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.23 (&#8722;0.46; &#8722;0.002)<sup><italic>p</italic>&#160;=&#160;0.048</sup></td>
###xml 1226 1348 1226 1348 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">BMD<sub>spine</sub></td><td char="." align="char">&#8722;0.21 (&#8722;0.40; &#8722;0.03)<sup><italic>p</italic>&#160;=&#160;0.02</sup></td><td char="." align="char">&#8722;0.20 (&#8722;0.37; &#8722;0.02)<sup><italic>p</italic>&#160;=&#160;0.01</sup></td><td char="." align="char">&#8722;0.26 (&#8722;0.51; &#8722;0.01)<sup><italic>p</italic>&#160;=&#160;0.04</sup></td><td char="." align="char">&#8722;0.23 (&#8722;0.46; &#8722;0.002)<sup><italic>p</italic>&#160;=&#160;0.048</sup></td></tr>
###xml 1351 1354 1351 1354 <sub xmlns:xlink="http://www.w3.org/1999/xlink">hip</sub>
###xml 1348 1354 1348 1354 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">BMD<sub>hip</sub></td>
###xml 1373 1375 1373 1375 <sup xmlns:xlink="http://www.w3.org/1999/xlink">NS</sup>
###xml 1354 1375 1354 1375 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.08 (&#8722;0.26; 0.09)<sup>NS</sup></td>
###xml 1394 1396 1394 1396 <sup xmlns:xlink="http://www.w3.org/1999/xlink">NS</sup>
###xml 1375 1396 1375 1396 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.06 (&#8722;0.22; 0.10)<sup>NS</sup></td>
###xml 1414 1416 1414 1416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">NS</sup>
###xml 1396 1416 1396 1416 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.08 (&#8722;0.33; 017)<sup>NS</sup></td>
###xml 1435 1437 1435 1437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">NS</sup>
###xml 1416 1437 1416 1437 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.07 (&#8722;0.32; 0.19)<sup>NS</sup></td>
###xml 1348 1437 1348 1437 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">BMD<sub>hip</sub></td><td char="." align="char">&#8722;0.08 (&#8722;0.26; 0.09)<sup>NS</sup></td><td char="." align="char">&#8722;0.06 (&#8722;0.22; 0.10)<sup>NS</sup></td><td char="." align="char">&#8722;0.08 (&#8722;0.33; 017)<sup>NS</sup></td><td char="." align="char">&#8722;0.07 (&#8722;0.32; 0.19)<sup>NS</sup></td></tr>
###xml 1440 1442 1440 1442 <sub xmlns:xlink="http://www.w3.org/1999/xlink">WB</sub>
###xml 1437 1442 1437 1442 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">BMD<sub>WB</sub></td>
###xml 1462 1463 1462 1463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1462 1470 1462 1470 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>p</italic>&#160;=&#160;0.04</sup>
###xml 1442 1470 1442 1470 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.17 (&#8722;0.33; &#8722;0.01)<sup><italic>p</italic>&#160;=&#160;0.04</sup></td>
###xml 1489 1490 1489 1490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1489 1497 1489 1497 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>p</italic>&#160;=&#160;0.07</sup>
###xml 1470 1497 1470 1497 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.15 (&#8722;0.30; 0.01)<sup><italic>p</italic>&#160;=&#160;0.07</sup></td>
###xml 1516 1518 1516 1518 <sup xmlns:xlink="http://www.w3.org/1999/xlink">NS</sup>
###xml 1497 1518 1497 1518 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.17 (&#8722;0.41; 0.08)<sup>NS</sup></td>
###xml 1537 1539 1537 1539 <sup xmlns:xlink="http://www.w3.org/1999/xlink">NS</sup>
###xml 1518 1539 1518 1539 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8722;0.18 (&#8722;0.44; 0.07)<sup>NS</sup></td>
###xml 1437 1539 1437 1539 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">BMD<sub>WB</sub></td><td char="." align="char">&#8722;0.17 (&#8722;0.33; &#8722;0.01)<sup><italic>p</italic>&#160;=&#160;0.04</sup></td><td char="." align="char">&#8722;0.15 (&#8722;0.30; 0.01)<sup><italic>p</italic>&#160;=&#160;0.07</sup></td><td char="." align="char">&#8722;0.17 (&#8722;0.41; 0.08)<sup>NS</sup></td><td char="." align="char">&#8722;0.18 (&#8722;0.44; 0.07)<sup>NS</sup></td></tr>
###xml 891 1539 891 1539 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left" colspan="5"><bold>Total population (</bold><bold><italic>n</italic></bold><bold>&#160;=&#160;779)</bold></td></tr><tr><td align="left">BMD<sub>spine</sub></td><td char="." align="char">&#8722;0.11 (&#8722;0.29; 0.06)<sup>NS</sup></td><td char="." align="char">&#8722;0.10 (&#8722;0.27; 0.06)<sup>NS</sup></td><td char="." align="char">&#8722;0.044 (&#8722;0.28; 0.19)<sup>NS</sup></td><td char="." align="char">&#8722;0.054 (&#8722;0.27; 0.16)<sup>NS</sup></td></tr><tr><td align="left">BMD<sub>hip</sub></td><td char="." align="char">&#8722;0.03 (&#8722;0.20; 0.11)<sup>NS</sup></td><td char="." align="char">&#8722;0.02 (&#8722;0.17; 0.11)<sup>NS</sup></td><td char="." align="char">0.018 (&#8722;0.20; 0.23)<sup>NS</sup></td><td char="." align="char">0.002 (&#8722;0.22; 0.21)<sup>NS</sup></td></tr><tr><td align="left">BMD<sub>WB</sub></td><td char="." align="char">&#8722;0.13 (&#8722;0.27; 0.11)<sup><italic>p</italic>&#160;=&#160;0.07</sup></td><td char="." align="char">&#8722;0.12 (&#8722;0.25; 0.01)<sup><italic>p</italic>&#160;=&#160;0.07</sup></td><td char="." align="char">&#8722;0.085 (&#8722;0.30; 0.13)<sup>NS</sup></td><td char="." align="char">&#8722;0.11 (&#8722;0.33; 0.10)<sup>NS</sup></td></tr><tr><td align="left" colspan="5"><bold>Non-sedentary (</bold><bold><italic>n</italic></bold><bold>&#160;=&#160;589)</bold></td></tr><tr><td align="left">BMD<sub>spine</sub></td><td char="." align="char">&#8722;0.21 (&#8722;0.40; &#8722;0.03)<sup><italic>p</italic>&#160;=&#160;0.02</sup></td><td char="." align="char">&#8722;0.20 (&#8722;0.37; &#8722;0.02)<sup><italic>p</italic>&#160;=&#160;0.01</sup></td><td char="." align="char">&#8722;0.26 (&#8722;0.51; &#8722;0.01)<sup><italic>p</italic>&#160;=&#160;0.04</sup></td><td char="." align="char">&#8722;0.23 (&#8722;0.46; &#8722;0.002)<sup><italic>p</italic>&#160;=&#160;0.048</sup></td></tr><tr><td align="left">BMD<sub>hip</sub></td><td char="." align="char">&#8722;0.08 (&#8722;0.26; 0.09)<sup>NS</sup></td><td char="." align="char">&#8722;0.06 (&#8722;0.22; 0.10)<sup>NS</sup></td><td char="." align="char">&#8722;0.08 (&#8722;0.33; 017)<sup>NS</sup></td><td char="." align="char">&#8722;0.07 (&#8722;0.32; 0.19)<sup>NS</sup></td></tr><tr><td align="left">BMD<sub>WB</sub></td><td char="." align="char">&#8722;0.17 (&#8722;0.33; &#8722;0.01)<sup><italic>p</italic>&#160;=&#160;0.04</sup></td><td char="." align="char">&#8722;0.15 (&#8722;0.30; 0.01)<sup><italic>p</italic>&#160;=&#160;0.07</sup></td><td char="." align="char">&#8722;0.17 (&#8722;0.41; 0.08)<sup>NS</sup></td><td char="." align="char">&#8722;0.18 (&#8722;0.44; 0.07)<sup>NS</sup></td></tr></tbody>
###xml 815 1539 815 1539 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" colspan="4">Polymorphism</th></tr><tr><th align="left" colspan="2">Ala1330Val</th><th align="left" colspan="2">Val667Met</th></tr><tr><th align="left">Z-score</th><th align="left">Unadjusted</th><th align="left">Adjusted<sup>a</sup></th><th align="left">Unadjusted</th><th align="left">Adjusted<sup>a</sup></th></tr></thead><tbody><tr><td align="left" colspan="5"><bold>Total population (</bold><bold><italic>n</italic></bold><bold>&#160;=&#160;779)</bold></td></tr><tr><td align="left">BMD<sub>spine</sub></td><td char="." align="char">&#8722;0.11 (&#8722;0.29; 0.06)<sup>NS</sup></td><td char="." align="char">&#8722;0.10 (&#8722;0.27; 0.06)<sup>NS</sup></td><td char="." align="char">&#8722;0.044 (&#8722;0.28; 0.19)<sup>NS</sup></td><td char="." align="char">&#8722;0.054 (&#8722;0.27; 0.16)<sup>NS</sup></td></tr><tr><td align="left">BMD<sub>hip</sub></td><td char="." align="char">&#8722;0.03 (&#8722;0.20; 0.11)<sup>NS</sup></td><td char="." align="char">&#8722;0.02 (&#8722;0.17; 0.11)<sup>NS</sup></td><td char="." align="char">0.018 (&#8722;0.20; 0.23)<sup>NS</sup></td><td char="." align="char">0.002 (&#8722;0.22; 0.21)<sup>NS</sup></td></tr><tr><td align="left">BMD<sub>WB</sub></td><td char="." align="char">&#8722;0.13 (&#8722;0.27; 0.11)<sup><italic>p</italic>&#160;=&#160;0.07</sup></td><td char="." align="char">&#8722;0.12 (&#8722;0.25; 0.01)<sup><italic>p</italic>&#160;=&#160;0.07</sup></td><td char="." align="char">&#8722;0.085 (&#8722;0.30; 0.13)<sup>NS</sup></td><td char="." align="char">&#8722;0.11 (&#8722;0.33; 0.10)<sup>NS</sup></td></tr><tr><td align="left" colspan="5"><bold>Non-sedentary (</bold><bold><italic>n</italic></bold><bold>&#160;=&#160;589)</bold></td></tr><tr><td align="left">BMD<sub>spine</sub></td><td char="." align="char">&#8722;0.21 (&#8722;0.40; &#8722;0.03)<sup><italic>p</italic>&#160;=&#160;0.02</sup></td><td char="." align="char">&#8722;0.20 (&#8722;0.37; &#8722;0.02)<sup><italic>p</italic>&#160;=&#160;0.01</sup></td><td char="." align="char">&#8722;0.26 (&#8722;0.51; &#8722;0.01)<sup><italic>p</italic>&#160;=&#160;0.04</sup></td><td char="." align="char">&#8722;0.23 (&#8722;0.46; &#8722;0.002)<sup><italic>p</italic>&#160;=&#160;0.048</sup></td></tr><tr><td align="left">BMD<sub>hip</sub></td><td char="." align="char">&#8722;0.08 (&#8722;0.26; 0.09)<sup>NS</sup></td><td char="." align="char">&#8722;0.06 (&#8722;0.22; 0.10)<sup>NS</sup></td><td char="." align="char">&#8722;0.08 (&#8722;0.33; 017)<sup>NS</sup></td><td char="." align="char">&#8722;0.07 (&#8722;0.32; 0.19)<sup>NS</sup></td></tr><tr><td align="left">BMD<sub>WB</sub></td><td char="." align="char">&#8722;0.17 (&#8722;0.33; &#8722;0.01)<sup><italic>p</italic>&#160;=&#160;0.04</sup></td><td char="." align="char">&#8722;0.15 (&#8722;0.30; 0.01)<sup><italic>p</italic>&#160;=&#160;0.07</sup></td><td char="." align="char">&#8722;0.17 (&#8722;0.41; 0.08)<sup>NS</sup></td><td char="." align="char">&#8722;0.18 (&#8722;0.44; 0.07)<sup>NS</sup></td></tr></tbody></table>
###xml 1539 1652 1539 1652 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="53">Data are shown as mean effect and 95% confidence interval. Z-scores were derived from the study population itself</p>
###xml 1652 1653 1652 1653 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1786 1787 1786 1787 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1652 1787 1652 1787 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="54"><sup>a</sup>Adjusted for BMI (ln-transformed), lean body mass (ln-transformed), smoking (0/1), any continuous medication (0/1), and serum 25-OH-D<sub>3</sub></p>
###xml 1539 1787 1539 1787 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="53">Data are shown as mean effect and 95% confidence interval. Z-scores were derived from the study population itself</p><p textid="54"><sup>a</sup>Adjusted for BMI (ln-transformed), lean body mass (ln-transformed), smoking (0/1), any continuous medication (0/1), and serum 25-OH-D<sub>3</sub></p></table-wrap-foot>
###xml 706 1787 706 1787 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="52">Multiple regression analysis determining the change in BMD Z-score for each copy of the T- or A-allele</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" colspan="4">Polymorphism</th></tr><tr><th align="left" colspan="2">Ala1330Val</th><th align="left" colspan="2">Val667Met</th></tr><tr><th align="left">Z-score</th><th align="left">Unadjusted</th><th align="left">Adjusted<sup>a</sup></th><th align="left">Unadjusted</th><th align="left">Adjusted<sup>a</sup></th></tr></thead><tbody><tr><td align="left" colspan="5"><bold>Total population (</bold><bold><italic>n</italic></bold><bold>&#160;=&#160;779)</bold></td></tr><tr><td align="left">BMD<sub>spine</sub></td><td char="." align="char">&#8722;0.11 (&#8722;0.29; 0.06)<sup>NS</sup></td><td char="." align="char">&#8722;0.10 (&#8722;0.27; 0.06)<sup>NS</sup></td><td char="." align="char">&#8722;0.044 (&#8722;0.28; 0.19)<sup>NS</sup></td><td char="." align="char">&#8722;0.054 (&#8722;0.27; 0.16)<sup>NS</sup></td></tr><tr><td align="left">BMD<sub>hip</sub></td><td char="." align="char">&#8722;0.03 (&#8722;0.20; 0.11)<sup>NS</sup></td><td char="." align="char">&#8722;0.02 (&#8722;0.17; 0.11)<sup>NS</sup></td><td char="." align="char">0.018 (&#8722;0.20; 0.23)<sup>NS</sup></td><td char="." align="char">0.002 (&#8722;0.22; 0.21)<sup>NS</sup></td></tr><tr><td align="left">BMD<sub>WB</sub></td><td char="." align="char">&#8722;0.13 (&#8722;0.27; 0.11)<sup><italic>p</italic>&#160;=&#160;0.07</sup></td><td char="." align="char">&#8722;0.12 (&#8722;0.25; 0.01)<sup><italic>p</italic>&#160;=&#160;0.07</sup></td><td char="." align="char">&#8722;0.085 (&#8722;0.30; 0.13)<sup>NS</sup></td><td char="." align="char">&#8722;0.11 (&#8722;0.33; 0.10)<sup>NS</sup></td></tr><tr><td align="left" colspan="5"><bold>Non-sedentary (</bold><bold><italic>n</italic></bold><bold>&#160;=&#160;589)</bold></td></tr><tr><td align="left">BMD<sub>spine</sub></td><td char="." align="char">&#8722;0.21 (&#8722;0.40; &#8722;0.03)<sup><italic>p</italic>&#160;=&#160;0.02</sup></td><td char="." align="char">&#8722;0.20 (&#8722;0.37; &#8722;0.02)<sup><italic>p</italic>&#160;=&#160;0.01</sup></td><td char="." align="char">&#8722;0.26 (&#8722;0.51; &#8722;0.01)<sup><italic>p</italic>&#160;=&#160;0.04</sup></td><td char="." align="char">&#8722;0.23 (&#8722;0.46; &#8722;0.002)<sup><italic>p</italic>&#160;=&#160;0.048</sup></td></tr><tr><td align="left">BMD<sub>hip</sub></td><td char="." align="char">&#8722;0.08 (&#8722;0.26; 0.09)<sup>NS</sup></td><td char="." align="char">&#8722;0.06 (&#8722;0.22; 0.10)<sup>NS</sup></td><td char="." align="char">&#8722;0.08 (&#8722;0.33; 017)<sup>NS</sup></td><td char="." align="char">&#8722;0.07 (&#8722;0.32; 0.19)<sup>NS</sup></td></tr><tr><td align="left">BMD<sub>WB</sub></td><td char="." align="char">&#8722;0.17 (&#8722;0.33; &#8722;0.01)<sup><italic>p</italic>&#160;=&#160;0.04</sup></td><td char="." align="char">&#8722;0.15 (&#8722;0.30; 0.01)<sup><italic>p</italic>&#160;=&#160;0.07</sup></td><td char="." align="char">&#8722;0.17 (&#8722;0.41; 0.08)<sup>NS</sup></td><td char="." align="char">&#8722;0.18 (&#8722;0.44; 0.07)<sup>NS</sup></td></tr></tbody></table><table-wrap-foot><p textid="53">Data are shown as mean effect and 95% confidence interval. Z-scores were derived from the study population itself</p><p textid="54"><sup>a</sup>Adjusted for BMI (ln-transformed), lean body mass (ln-transformed), smoking (0/1), any continuous medication (0/1), and serum 25-OH-D<sub>3</sub></p></table-wrap-foot></table-wrap>
Table 2 shows the gene-dose effect on BMD expressed as the change in Z-score of each copy of the T- or A-allele, respectively. The analysis was performed both with and without adjustment for BMI, smoking (0/1), any continuous medication (0/1), and serum 25-OH-D3 in the overall study population (multiple regression analysis). Regarding the Ala1330Val polymorphism, whole-body BMD tended to decrease with each copy of the T-allele (p = 0.07) in the overall study population (n = 779). No significant association between number of T-alleles and BMD at the other skeletal sites was found. Regarding the Val667Met polymorphism, no significant gene-dose effect could be demonstrated in the overall population. Table 2Multiple regression analysis determining the change in BMD Z-score for each copy of the T- or A-allelePolymorphismAla1330ValVal667MetZ-scoreUnadjustedAdjustedaUnadjustedAdjustedaTotal population (n = 779)BMDspine-0.11 (-0.29; 0.06)NS-0.10 (-0.27; 0.06)NS-0.044 (-0.28; 0.19)NS-0.054 (-0.27; 0.16)NSBMDhip-0.03 (-0.20; 0.11)NS-0.02 (-0.17; 0.11)NS0.018 (-0.20; 0.23)NS0.002 (-0.22; 0.21)NSBMDWB-0.13 (-0.27; 0.11)p = 0.07-0.12 (-0.25; 0.01)p = 0.07-0.085 (-0.30; 0.13)NS-0.11 (-0.33; 0.10)NSNon-sedentary (n = 589)BMDspine-0.21 (-0.40; -0.03)p = 0.02-0.20 (-0.37; -0.02)p = 0.01-0.26 (-0.51; -0.01)p = 0.04-0.23 (-0.46; -0.002)p = 0.048BMDhip-0.08 (-0.26; 0.09)NS-0.06 (-0.22; 0.10)NS-0.08 (-0.33; 017)NS-0.07 (-0.32; 0.19)NSBMDWB-0.17 (-0.33; -0.01)p = 0.04-0.15 (-0.30; 0.01)p = 0.07-0.17 (-0.41; 0.08)NS-0.18 (-0.44; 0.07)NSData are shown as mean effect and 95% confidence interval. Z-scores were derived from the study population itselfaAdjusted for BMI (ln-transformed), lean body mass (ln-transformed), smoking (0/1), any continuous medication (0/1), and serum 25-OH-D3
###end p 51
###begin p 52
Multiple regression analysis determining the change in BMD Z-score for each copy of the T- or A-allele
###end p 52
###begin p 53
Data are shown as mean effect and 95% confidence interval. Z-scores were derived from the study population itself
###end p 53
###begin p 54
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 134 135 134 135 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
aAdjusted for BMI (ln-transformed), lean body mass (ln-transformed), smoking (0/1), any continuous medication (0/1), and serum 25-OH-D3
###end p 54
###begin p 55
###xml 51 52 51 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 244 245 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 316 317 316 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 333 334 333 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 480 481 480 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 535 536 535 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 556 562 556 562 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 867 870 865 868 <sup xmlns:xlink="http://www.w3.org/1999/xlink">(*)</sup>
###xml 870 871 868 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 881 882 879 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 562 889 562 887 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="56">BMD of the lumbar spine, total hip, and whole body in relation to the genotype regarding the Ala1330Val (upper panel) and the Val667Met (lower panel) polymorphisms in the LRP5 gene. Participants with a non-sedentary (left) and sedentary lifestyle (right) are displayed. Data are shown as the mean&#160;&#177;&#160;SE. <sup>(*)</sup><italic>p</italic>&#160;&lt;&#160;0.10, *<italic>p</italic>&#160;&lt;&#160;0.05</p>
###xml 562 889 562 887 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="56">BMD of the lumbar spine, total hip, and whole body in relation to the genotype regarding the Ala1330Val (upper panel) and the Val667Met (lower panel) polymorphisms in the LRP5 gene. Participants with a non-sedentary (left) and sedentary lifestyle (right) are displayed. Data are shown as the mean&#160;&#177;&#160;SE. <sup>(*)</sup><italic>p</italic>&#160;&lt;&#160;0.10, *<italic>p</italic>&#160;&lt;&#160;0.05</p></caption>
###xml 889 889 887 887 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="223_2007_9088_Fig1_HTML" id="MO1"/>
###xml 556 889 556 887 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="56">BMD of the lumbar spine, total hip, and whole body in relation to the genotype regarding the Ala1330Val (upper panel) and the Val667Met (lower panel) polymorphisms in the LRP5 gene. Participants with a non-sedentary (left) and sedentary lifestyle (right) are displayed. Data are shown as the mean&#160;&#177;&#160;SE. <sup>(*)</sup><italic>p</italic>&#160;&lt;&#160;0.10, *<italic>p</italic>&#160;&lt;&#160;0.05</p></caption><graphic position="anchor" xlink:href="223_2007_9088_Fig1_HTML" id="MO1"/></fig>
###xml 46 49 <span type="species:ncbi:9606">men</span>
###xml 744 756 <span type="species:ncbi:9606">Participants</span>
When analysis was restricted to non-sedentary men (n = 589), however, a significant correlation between the number of T-alleles at the Ala1330Val polymorphism and BMD in the spine was found in both the unadjusted (-0.21 [95% CI: -0.40; -0.03], p = 0.02) (Fig. 1) and adjusted analysis (-0.20 [95% CI: -0.37; -0.02], p = 0.01) (Table 2). Similarly, each copy of the A-allele in the Val667Met polymorphism decreased the lumbar spine BMD in unadjusted (-0.26 [95% CI: -0.51; -0.01], p = 0.04) and adjusted (-0.23 [95% CI: -0.46; -0.002], p = 0.048) analysis. Fig. 1BMD of the lumbar spine, total hip, and whole body in relation to the genotype regarding the Ala1330Val (upper panel) and the Val667Met (lower panel) polymorphisms in the LRP5 gene. Participants with a non-sedentary (left) and sedentary lifestyle (right) are displayed. Data are shown as the mean +/- SE. (*)p < 0.10, *p < 0.05
###end p 55
###begin p 56
###xml 305 308 303 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">(*)</sup>
###xml 308 309 306 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 319 320 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 182 194 <span type="species:ncbi:9606">Participants</span>
BMD of the lumbar spine, total hip, and whole body in relation to the genotype regarding the Ala1330Val (upper panel) and the Val667Met (lower panel) polymorphisms in the LRP5 gene. Participants with a non-sedentary (left) and sedentary lifestyle (right) are displayed. Data are shown as the mean +/- SE. (*)p < 0.10, *p < 0.05
###end p 56
###begin title 57
Genotypes in Relation to Bone Markers
###end title 57
###begin p 58
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
No significant differences were observed between genotypes of the Ala1330Val or Val667Met polymorphisms regarding bone markers (Table 1).
###end p 58
###begin title 59
Haplotype Analysis
###end title 59
###begin p 60
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab3" ref-type="table">3</xref>
###xml 327 334 327 334 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;3</label>
###xml 334 471 334 471 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="61">The effect of haplotypes of Ala1330Val and Val667Met polymorphisms on BMD adjusted for BMI, lean body mass, smoking, drugs, and vitamin D</p>
###xml 334 471 334 471 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="61">The effect of haplotypes of Ala1330Val and Val667Met polymorphisms on BMD adjusted for BMI, lean body mass, smoking, drugs, and vitamin D</p></caption>
###xml 471 471 471 471 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 471 481 471 481 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="4">Haplotypes</th>
###xml 481 481 481 481 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 471 481 471 481 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left"/><th align="left" colspan="4">Haplotypes</th><th align="left"/></tr>
###xml 481 491 481 491 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Ala1330Val</th>
###xml 491 492 491 492 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">C</th>
###xml 492 493 492 493 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">T</th>
###xml 493 493 493 493 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 481 493 481 493 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Ala1330Val</th><th align="left" colspan="2">C</th><th align="left" colspan="2">T</th><th align="left"/></tr>
###xml 471 493 471 493 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left"/><th align="left" colspan="4">Haplotypes</th><th align="left"/></tr><tr><th align="left">Ala1330Val</th><th align="left" colspan="2">C</th><th align="left" colspan="2">T</th><th align="left"/></tr></thead>
###xml 493 502 493 502 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Val667Met</td>
###xml 502 503 502 503 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">G</td>
###xml 503 504 503 504 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">A</td>
###xml 504 505 504 505 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">G</td>
###xml 505 506 505 506 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">A</td>
###xml 506 507 506 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 506 507 506 507 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>p</italic></td>
###xml 493 507 493 507 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Val667Met</td><td align="left">G</td><td align="left">A</td><td align="left">G</td><td align="left">A</td><td align="left"><italic>p</italic></td></tr>
###xml 507 508 507 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 507 508 507 508 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>n</italic></td>
###xml 508 512 508 512 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1331</td>
###xml 512 513 512 513 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3</td>
###xml 513 516 513 516 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">129</td>
###xml 516 518 516 518 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">81</td>
###xml 518 518 518 518 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 507 518 507 518 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>n</italic></td><td align="left">1331</td><td align="left">3</td><td align="left">129</td><td align="left">81</td><td align="left"/></tr>
###xml 521 526 521 526 <sub xmlns:xlink="http://www.w3.org/1999/xlink">spine</sub>
###xml 532 533 532 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 518 534 518 534 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">BMD<sub>spine</sub> (g/cm<sup>2</sup>)</td>
###xml 534 548 534 546 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">0.008&#160;&#177;&#160;0.96</td>
###xml 548 562 546 558 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">&#8722;0.42&#160;&#177;&#160;0.65</td>
###xml 562 576 558 570 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">&#8722;0.09&#160;&#177;&#160;0.90</td>
###xml 576 590 570 582 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">&#8722;0.04&#160;&#177;&#160;1.60</td>
###xml 590 592 582 584 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 518 592 518 584 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">BMD<sub>spine</sub> (g/cm<sup>2</sup>)</td><td char="&#177;" align="char">0.008&#160;&#177;&#160;0.96</td><td char="&#177;" align="char">&#8722;0.42&#160;&#177;&#160;0.65</td><td char="&#177;" align="char">&#8722;0.09&#160;&#177;&#160;0.90</td><td char="&#177;" align="char">&#8722;0.04&#160;&#177;&#160;1.60</td><td align="left">NS</td></tr>
###xml 595 598 587 590 <sub xmlns:xlink="http://www.w3.org/1999/xlink">hip</sub>
###xml 604 605 596 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 592 606 584 598 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">BMD<sub>hip</sub> (g/cm<sup>2</sup>)</td>
###xml 606 621 598 611 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">&#8722;0.002&#160;&#177;&#160;1.01</td>
###xml 621 634 611 622 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">0.97&#160;&#177;&#160;1.48</td>
###xml 634 650 622 636 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">&#8722;0.0005&#160;&#177;&#160;0.95</td>
###xml 650 663 636 647 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">&#8722;0.04&#160;&#177;&#160;1.0</td>
###xml 663 665 647 649 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 592 665 584 649 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">BMD<sub>hip</sub> (g/cm<sup>2</sup>)</td><td char="&#177;" align="char">&#8722;0.002&#160;&#177;&#160;1.01</td><td char="&#177;" align="char">0.97&#160;&#177;&#160;1.48</td><td char="&#177;" align="char">&#8722;0.0005&#160;&#177;&#160;0.95</td><td char="&#177;" align="char">&#8722;0.04&#160;&#177;&#160;1.0</td><td align="left">NS</td></tr>
###xml 668 670 652 654 <sub xmlns:xlink="http://www.w3.org/1999/xlink">WB</sub>
###xml 676 677 660 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 665 678 649 662 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">BMD<sub>WB</sub> (g/cm<sup>2</sup>)</td>
###xml 678 691 662 673 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">0.02&#160;&#177;&#160;1.01</td>
###xml 691 704 673 684 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">0.70&#160;&#177;&#160;0.59</td>
###xml 704 718 684 696 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">&#8722;0.10&#160;&#177;&#160;0.87</td>
###xml 718 732 696 708 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">&#8722;0.14&#160;&#177;&#160;1.04</td>
###xml 732 734 708 710 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">NS</td>
###xml 665 734 649 710 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">BMD<sub>WB</sub> (g/cm<sup>2</sup>)</td><td char="&#177;" align="char">0.02&#160;&#177;&#160;1.01</td><td char="&#177;" align="char">0.70&#160;&#177;&#160;0.59</td><td char="&#177;" align="char">&#8722;0.10&#160;&#177;&#160;0.87</td><td char="&#177;" align="char">&#8722;0.14&#160;&#177;&#160;1.04</td><td align="left">NS</td></tr>
###xml 493 734 493 710 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">Val667Met</td><td align="left">G</td><td align="left">A</td><td align="left">G</td><td align="left">A</td><td align="left"><italic>p</italic></td></tr><tr><td align="left"><italic>n</italic></td><td align="left">1331</td><td align="left">3</td><td align="left">129</td><td align="left">81</td><td align="left"/></tr><tr><td align="left">BMD<sub>spine</sub> (g/cm<sup>2</sup>)</td><td char="&#177;" align="char">0.008&#160;&#177;&#160;0.96</td><td char="&#177;" align="char">&#8722;0.42&#160;&#177;&#160;0.65</td><td char="&#177;" align="char">&#8722;0.09&#160;&#177;&#160;0.90</td><td char="&#177;" align="char">&#8722;0.04&#160;&#177;&#160;1.60</td><td align="left">NS</td></tr><tr><td align="left">BMD<sub>hip</sub> (g/cm<sup>2</sup>)</td><td char="&#177;" align="char">&#8722;0.002&#160;&#177;&#160;1.01</td><td char="&#177;" align="char">0.97&#160;&#177;&#160;1.48</td><td char="&#177;" align="char">&#8722;0.0005&#160;&#177;&#160;0.95</td><td char="&#177;" align="char">&#8722;0.04&#160;&#177;&#160;1.0</td><td align="left">NS</td></tr><tr><td align="left">BMD<sub>WB</sub> (g/cm<sup>2</sup>)</td><td char="&#177;" align="char">0.02&#160;&#177;&#160;1.01</td><td char="&#177;" align="char">0.70&#160;&#177;&#160;0.59</td><td char="&#177;" align="char">&#8722;0.10&#160;&#177;&#160;0.87</td><td char="&#177;" align="char">&#8722;0.14&#160;&#177;&#160;1.04</td><td align="left">NS</td></tr></tbody>
###xml 471 734 471 710 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left" colspan="4">Haplotypes</th><th align="left"/></tr><tr><th align="left">Ala1330Val</th><th align="left" colspan="2">C</th><th align="left" colspan="2">T</th><th align="left"/></tr></thead><tbody><tr><td align="left">Val667Met</td><td align="left">G</td><td align="left">A</td><td align="left">G</td><td align="left">A</td><td align="left"><italic>p</italic></td></tr><tr><td align="left"><italic>n</italic></td><td align="left">1331</td><td align="left">3</td><td align="left">129</td><td align="left">81</td><td align="left"/></tr><tr><td align="left">BMD<sub>spine</sub> (g/cm<sup>2</sup>)</td><td char="&#177;" align="char">0.008&#160;&#177;&#160;0.96</td><td char="&#177;" align="char">&#8722;0.42&#160;&#177;&#160;0.65</td><td char="&#177;" align="char">&#8722;0.09&#160;&#177;&#160;0.90</td><td char="&#177;" align="char">&#8722;0.04&#160;&#177;&#160;1.60</td><td align="left">NS</td></tr><tr><td align="left">BMD<sub>hip</sub> (g/cm<sup>2</sup>)</td><td char="&#177;" align="char">&#8722;0.002&#160;&#177;&#160;1.01</td><td char="&#177;" align="char">0.97&#160;&#177;&#160;1.48</td><td char="&#177;" align="char">&#8722;0.0005&#160;&#177;&#160;0.95</td><td char="&#177;" align="char">&#8722;0.04&#160;&#177;&#160;1.0</td><td align="left">NS</td></tr><tr><td align="left">BMD<sub>WB</sub> (g/cm<sup>2</sup>)</td><td char="&#177;" align="char">0.02&#160;&#177;&#160;1.01</td><td char="&#177;" align="char">0.70&#160;&#177;&#160;0.59</td><td char="&#177;" align="char">&#8722;0.10&#160;&#177;&#160;0.87</td><td char="&#177;" align="char">&#8722;0.14&#160;&#177;&#160;1.04</td><td align="left">NS</td></tr></tbody></table>
###xml 734 908 710 882 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="62">Data are shown as the mean&#160;&#177;&#160;SD. No significant associations between BMD and haplotypes were found when sedentary and non-sedentary men were analyzed separately (not shown)</p>
###xml 734 908 710 882 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="62">Data are shown as the mean&#160;&#177;&#160;SD. No significant associations between BMD and haplotypes were found when sedentary and non-sedentary men were analyzed separately (not shown)</p></table-wrap-foot>
###xml 327 908 327 882 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab3"><label>Table&#160;3</label><caption><p textid="61">The effect of haplotypes of Ala1330Val and Val667Met polymorphisms on BMD adjusted for BMI, lean body mass, smoking, drugs, and vitamin D</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left" colspan="4">Haplotypes</th><th align="left"/></tr><tr><th align="left">Ala1330Val</th><th align="left" colspan="2">C</th><th align="left" colspan="2">T</th><th align="left"/></tr></thead><tbody><tr><td align="left">Val667Met</td><td align="left">G</td><td align="left">A</td><td align="left">G</td><td align="left">A</td><td align="left"><italic>p</italic></td></tr><tr><td align="left"><italic>n</italic></td><td align="left">1331</td><td align="left">3</td><td align="left">129</td><td align="left">81</td><td align="left"/></tr><tr><td align="left">BMD<sub>spine</sub> (g/cm<sup>2</sup>)</td><td char="&#177;" align="char">0.008&#160;&#177;&#160;0.96</td><td char="&#177;" align="char">&#8722;0.42&#160;&#177;&#160;0.65</td><td char="&#177;" align="char">&#8722;0.09&#160;&#177;&#160;0.90</td><td char="&#177;" align="char">&#8722;0.04&#160;&#177;&#160;1.60</td><td align="left">NS</td></tr><tr><td align="left">BMD<sub>hip</sub> (g/cm<sup>2</sup>)</td><td char="&#177;" align="char">&#8722;0.002&#160;&#177;&#160;1.01</td><td char="&#177;" align="char">0.97&#160;&#177;&#160;1.48</td><td char="&#177;" align="char">&#8722;0.0005&#160;&#177;&#160;0.95</td><td char="&#177;" align="char">&#8722;0.04&#160;&#177;&#160;1.0</td><td align="left">NS</td></tr><tr><td align="left">BMD<sub>WB</sub> (g/cm<sup>2</sup>)</td><td char="&#177;" align="char">0.02&#160;&#177;&#160;1.01</td><td char="&#177;" align="char">0.70&#160;&#177;&#160;0.59</td><td char="&#177;" align="char">&#8722;0.10&#160;&#177;&#160;0.87</td><td char="&#177;" align="char">&#8722;0.14&#160;&#177;&#160;1.04</td><td align="left">NS</td></tr></tbody></table><table-wrap-foot><p textid="62">Data are shown as the mean&#160;&#177;&#160;SD. No significant associations between BMD and haplotypes were found when sedentary and non-sedentary men were analyzed separately (not shown)</p></table-wrap-foot></table-wrap>
###xml 285 288 <span type="species:ncbi:9606">men</span>
###xml 868 871 <span type="species:ncbi:9606">men</span>
The effect of haplotypes of the Ala1330Val and Val667Met polymorphisms on BMD adjusted for BMI, lean body mass, smoking, drugs, and vitamin D are shown in Table 3. No significant association between BMD and haplotypes was found. This was also the case when sedentary and non-sedentary men were analyzed separately (not shown). Table 3The effect of haplotypes of Ala1330Val and Val667Met polymorphisms on BMD adjusted for BMI, lean body mass, smoking, drugs, and vitamin DHaplotypesAla1330ValCTVal667MetGAGApn1331312981BMDspine (g/cm2)0.008 +/- 0.96-0.42 +/- 0.65-0.09 +/- 0.90-0.04 +/- 1.60NSBMDhip (g/cm2)-0.002 +/- 1.010.97 +/- 1.48-0.0005 +/- 0.95-0.04 +/- 1.0NSBMDWB (g/cm2)0.02 +/- 1.010.70 +/- 0.59-0.10 +/- 0.87-0.14 +/- 1.04NSData are shown as the mean +/- SD. No significant associations between BMD and haplotypes were found when sedentary and non-sedentary men were analyzed separately (not shown)
###end p 60
###begin p 61
The effect of haplotypes of Ala1330Val and Val667Met polymorphisms on BMD adjusted for BMI, lean body mass, smoking, drugs, and vitamin D
###end p 61
###begin p 62
###xml 134 137 <span type="species:ncbi:9606">men</span>
Data are shown as the mean +/- SD. No significant associations between BMD and haplotypes were found when sedentary and non-sedentary men were analyzed separately (not shown)
###end p 62
###begin title 63
Discussion
###end title 63
###begin p 64
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 714 715 714 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 124 127 <span type="species:ncbi:9606">men</span>
###xml 398 401 <span type="species:ncbi:9606">men</span>
###xml 545 549 <span type="species:ncbi:9606">boys</span>
We found a significant association between the Ala1330Val and the Val667Met polymorphisms in the LRP5 gene and BMD in young men, especially when physical activity was taken into account as confounder. This finding supports a number of recent papers reporting significant associations between polymorphisms in this gene and BMD [18, 19, 21, 22]. Some of these studies involved or were restricted to men [18, 22, 29, 30]. Moreover, Ferrari et al. [18] suggested that the polymorphisms in the LRP5 gene are associated with bone gain in prepubertal boys. Only one study [25] failed to demonstrate an association between variations in the LRP5 gene and BMD, but most likely this is due to their restricted sample size (n = 219).
###end p 64
###begin p 65
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 652 654 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">32</xref>
###xml 681 682 681 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
###xml 688 690 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR34">34</xref>
###xml 797 799 797 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 984 986 984 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 1274 1276 1274 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 1308 1310 1308 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 1663 1664 1663 1664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1997 1998 1997 1998 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 2700 2702 2700 2702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 2775 2777 2775 2777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">35</xref>
###xml 2895 2897 2895 2897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">36</xref>
###xml 3034 3036 3034 3036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 731 734 <span type="species:ncbi:9606">men</span>
###xml 1024 1029 <span type="species:ncbi:9606">women</span>
###xml 1612 1624 <span type="species:ncbi:9606">participants</span>
Major disruption of the LRP5 gene (homozygous nonsense or frame-shift mutations) resulting in loss-of-function has been demonstrated to be responsible for the osteoporosis pseudoglioma syndrome [16]. Conversely, a number of dominantly inherited gain-of-function mutations result in high bone mass phenotypes [12-14] and autosomal dominant osteopetrosis type 1 [14]. Minor changes in this gene, i.e., frequently occurring polymorphisms, may also be of importance in the regulation of bone mass as suggested by the association studies mentioned above. Further support comes from mapping a quantitative trait locus for BMD to chromosome 11q12-13 in some [31, 32] but not all studies [7, 33, 34]. In a case-control study comprising 78 men with idiopathic osteoporosis and 86 controls, Ferrari et al. [23] found that Ala1330Val and Val667Met conferred an odds ratio for osteoporosis of 2.98 (95% CI: 1.03-8.81) and 3.27 (95% CI: 1.43-7.44), respectively. Also, a single prospective study [21] comprising 1,301 elderly Australian women demonstrated that the c.3357A > G (rs556442) polymorphism was associated with decreased BMD and increased incidence of fractures. This polymorphism located in exon 15 is synonymous but was found to be in linkage disequilibrium with Ala1330Val [21]. Similarly, Mizuguchi et al. [19] found a linkage equilibrium block comprising exons 7 to 18. In our study, no significant effect of Ala1330Val or Val667Met on BMD was found apart from the ANOVA analysis which suggested that the AA genotype at Val667Met was associated with low BMD of the hip and increased body height. The number of participants with this genotype, however, was low (n = 4) and we found no significant gene-dose effect to back this finding. In non-sedentary subjects, however, we found a significant association between Ala1330Val genotype and the Val667Met and Z-score BMD in the spine both in unadjusted analysis and when adjusted for BMI, smoking, continuous medication, and serum levels of 25-OH-D3. Further, we observed an association between Ala1330Val and whole-body BMD in the unadjusted analysis. This interaction between lifestyle (sedentary/non-sedentary), LRP5 genotype, and BMD has not previously been reported. Such an association is fully in line with the proposed role of LRP5 as a player in adapting bone to weight-bearing. LRP5 acts as a co-receptor for Wnt proteins and is expressed in the osteoblast and a number of other cell types. The Ala1330Val (exon 18) polymorphism results in a substitution of alanine with the chemically similar valine. No functional studies have been performed on this polymorphism; however, the polymorphism is located within the second LDL-repeat of LRP5 [22] and this region is involved in the ligand binding of the LDL-receptor [35]. Also, preliminary results have shown that drugs that inhibit Dkk binding to LRP5 increase bone formation in vitro [36] and LRP5 seems to be involved in the adaptive response of bone to mechanical load and may be partly responsible for the "mechanostat" [11]. It is presently unclear why association between the Ala1330Val and Val667Met genotypes and BMD was found only in the spine and not in the hip in the non-sedentary group. Differences between the skeletal sites regarding loading pattern (compression vs. bending) and bone architecture (trabecular vs. cortical) may be important.
###end p 65
###begin p 66
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">37</xref>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR38">38</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR39">39</xref>
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR40">40</xref>
###xml 592 594 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR41">41</xref>
###xml 802 804 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR42">42</xref>
###xml 204 216 <span type="species:ncbi:9606">participants</span>
###xml 322 327 <span type="species:ncbi:9606">women</span>
###xml 332 335 <span type="species:ncbi:9606">men</span>
###xml 340 345 <span type="species:ncbi:9606">women</span>
###xml 424 429 <span type="species:ncbi:9606">women</span>
###xml 671 674 <span type="species:ncbi:9606">men</span>
###xml 780 783 <span type="species:ncbi:9606">men</span>
In our study, the numbers of T-alleles and A-alleles of the Ala1330Val and Val667Met polymorphisms, respectively, were associated with a decrease in BMD of the lumbar spine of 0.2 SD in the non-sedentary participants (i.e., approximately 2.5%). Previous studies have assessed this impact to be from 1% [20] to 15% [18] in women and men and women, respectively. While a number of genes have been associated with bone mass in women (e.g., PTH [37], alpha-1 chain of type 1 collagen [10], vitamin D receptor [38], transforming growth factor beta-1 [39], interleukin-6 [40], and osteoprotegerin [41]), only a few genes have been shown to be associated with peak bone mass in men. We have previously reported that the MTHFR gene is associated with peak bone mass in the same series of men as reported here [42]. Each of these polymorphisms including the LRP5 gene only accounts for a fraction of the variability in BMD; however, the 2.5% impact suggested by our study is not trivial.
###end p 66
###begin p 67
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
###xml 392 393 392 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
We found no association between either projected bone area at the spine or hip, or body weight and any of the polymorphisms; however, our data demonstrated a significant impact of the AA genotype of the Val667Met polymorphism and body height as previously reported by Ferrari et al. [18] and Koay et al. [29]. In our study, the number of subjects with the AA genotype was, however, very low (n = 4). Thus, this finding clearly needs confirmation in other study designs.
###end p 67
###begin p 68
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
The allele frequencies found in our study corresponded closely to those reported in Dutch, Australian, Japanese, and Korean populations [19, 21, 22, 30].
###end p 68
###begin p 69
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 951 952 951 952 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1055 1056 1055 1056 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 444 449 <span type="species:ncbi:9606">women</span>
###xml 542 554 <span type="species:ncbi:9606">participants</span>
Our study has some limitations. We only tested two polymorphisms in the LRP5 gene. We cannot, therefore, rule out the possibility that the associations found in our study could be due to other polymorphisms in the LRP5 gene or even in neighboring genes in linkage with the polymorphisms tested. Indeed, Bollerslev et al. [21] found that several of the polymorphisms in the LRP5 gene were in linkage disequilibrium with each other in Australian women. In our study, haplotype analyses were negative. This might be due to the limited number of participants. Testing large arrays of polymorphisms or haplotypes in relation to many outcome variables (i.e., bone mass at several skeletal sites), however, carry an increased risk of detecting spurious associations. Also, our study had a limited size. Given the observed genotype frequency and BMD values, our study had the power to detect differences in BMDof the spine between CC and CT + TT of 0.037 g/cm2 (alpha = 0.05 and beta = 0.80). Similarly, our study had the power to detect differences of 0.070 g/cm2 between GG and GA + AA in the overall analysis.
###end p 69
###begin p 70
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 130 142 <span type="species:ncbi:9606">participants</span>
###xml 179 191 <span type="species:ncbi:9606">participants</span>
###xml 359 371 <span type="species:ncbi:9606">participants</span>
###xml 583 595 <span type="species:ncbi:9606">participants</span>
###xml 740 743 <span type="species:ncbi:9606">men</span>
Our study also has several strengths. First, it was population-based. In contrast to most similar studies [18, 20] that recruited participants by advertisements, we recruited our participants by direct mailing on the basis of the National Personal Registry that includes all Danish citizens. This enabled us to account meticulously for the recruitment of our participants. Thus, our sample was not skewed with respect to key socio-economic parameters [24]. Second, our population had a relatively homogeneous genetic background both due to a small influx to our population and since participants with a first- or second-generation immigrant background were excluded on the basis on data from our national registry. Third, we selected young men aged 20-30 years since these were expected to have reached their peak bone mass. This was confirmed by our data demonstrating an infinitesimal decrease in BMD by age. Moreover, very few were afflicted with chronic diseases or had long-term exposure of environmental factors that may affect bone mass.
###end p 70
###begin p 71
###xml 179 182 <span type="species:ncbi:9606">men</span>
###xml 421 424 <span type="species:ncbi:9606">men</span>
We conclude that the Ala1330Val (exon 18) and Val667Met (exon 9) polymorphisms of the LRP5 gene are significantly associated with lumbar spine peak bone mass in physically active men, potentially accounting for 2.5% of BMD in the spine. This gene-environment interaction provides support for LRP5 as a mediator of load-induced bone formation and suggests that this gene is involved in the pathogenesis of osteoporosis in men.
###end p 71
###begin p 72
Mrs. Irmelin Krabbe, Donna Artbuckle, Bente Tot, Kirsten Westerman, Rikke Kiilshoj, Annette Madsen, and Fenna de Freitas are thanked for skillful technical assistance. The project was supported by WADA (World Anti Doping Agency). Moreover, Novo Nordisk A/S, Pfeizer A/S, Kulturministeriets Udvalg for Idraetsforskning (The Danish Ministry of Culture), Overlaegeradets Legatudvalg, Odense University Hospital, The Research Foundation and Clinical Institute, University of Southern Denmark contributed financial support. This project was also funded by a research grant from the European Union (GENOMOS) and by a research grant (G.0117.06) from the Fonds voor wetenschappelijk onderzoek (FWO), both to W.V.H. S.B. holds a specialization scholarship from the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen). W.B. holds a post-doctoral fellowship from the FWO.
###end p 72
###begin p 73
Data from this study were presented at the 33rd European Symposium on Calcified Tissues, Prague, May 13, 2006.
###end p 73
###begin p 74
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 74
###begin title 75
References
###end title 75
###begin article-title 76
Genetic determinants of bone mass in adults: A twin study
###end article-title 76
###begin article-title 77
Genetic epidemiological approaches to the search for osteoporosis genes
###end article-title 77
###begin article-title 78
###xml 37 42 <span type="species:ncbi:9606">women</span>
Bone density determinants in elderly women: A twin study
###end article-title 78
###begin article-title 79
Heritable and life-style determinants of bone mineral density
###end article-title 79
###begin article-title 80
Genetic factors in determining bone mass
###end article-title 80
###begin article-title 81
Determinants of bone mass in 10- to 26-year-old females: A twin study
###end article-title 81
###begin article-title 82
###xml 116 119 <span type="species:ncbi:9606">men</span>
Sex-specific and non-sex-specific quantitative trait loci contribute to normal variation in bone mineral density in men
###end article-title 82
###begin article-title 83
###xml 89 92 <span type="species:ncbi:9606">men</span>
The roles of adulthood behavioural factors and familial influences in bone density among men
###end article-title 83
###begin article-title 84
Gender differences in the genetic factors responsible for variation in bone density and ultrasound
###end article-title 84
###begin article-title 85
Genetics of osteoporosis
###end article-title 85
###begin article-title 86
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Bone biomechanical properties in LRP5 mutant mice
###end article-title 86
###begin article-title 87
A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait
###end article-title 87
###begin article-title 88
High bone density due to a mutation in LDL-receptor-related protein 5
###end article-title 88
###begin article-title 89
Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density
###end article-title 89
###begin article-title 90
###xml 18 22 <span type="species:ncbi:10090">mice</span>
High bone mass in mice expressing a mutant LRP5 gene
###end article-title 90
###begin article-title 91
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development
###end article-title 91
###begin article-title 92
###xml 116 120 <span type="species:ncbi:10090">mice</span>
Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor
###end article-title 92
###begin article-title 93
Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites
###end article-title 93
###begin article-title 94
LRP5, low-density-lipoprotein-receptor-related protein 5, is a determinant for bone mineral density
###end article-title 94
###begin article-title 95
###xml 65 70 <span type="species:ncbi:9606">women</span>
Contribution of the LRP5 gene to normal variation in peak BMD in women
###end article-title 95
###begin article-title 96
###xml 87 92 <span type="species:ncbi:9606">women</span>
LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women
###end article-title 96
###begin article-title 97
###xml 137 140 <span type="species:ncbi:9606">men</span>
Common genetic variation of the low-density lipoprotein receptor-related protein 5 and 6 genes determines fracture risk in elderly white men
###end article-title 97
###begin article-title 98
###xml 55 58 <span type="species:ncbi:9606">men</span>
LRP5 gene polymorphisms and idiopathic osteoporosis in men
###end article-title 98
###begin article-title 99
###xml 85 88 <span type="species:ncbi:9606">men</span>
Prevalence of overweight, obesity, and physical inactivity in 20-29 year-old, Danish men. relation to sociodemography, physical dysfunction, and low socioeconomic status: The Odense Androgen Study
###end article-title 99
###begin article-title 100
###xml 77 82 <span type="species:ncbi:9606">human</span>
Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II
###end article-title 100
###begin article-title 101
GOLD-graphical overview of linkage disequilibrium
###end article-title 101
###begin article-title 102
Maximum-likelihood estimation of haplotype frequencies in nuclear families
###end article-title 102
###begin article-title 103
Influence of LRP5 polymorphisms on normal variation in BMD
###end article-title 103
###begin article-title 104
###xml 111 114 <span type="species:ncbi:9606">men</span>
Association between bone mineral density and LDL receptor-related protein 5 gene polymorphisms in young Korean men
###end article-title 104
###begin article-title 105
Linkage of a QTL contributing to normal variation in bone mineral density to chromosome 11q12-13
###end article-title 105
###begin article-title 106
Genome screen for QTLs contributing to normal variation in bone mineral density and osteoporosis
###end article-title 106
###begin article-title 107
###xml 47 50 <span type="species:ncbi:9606">men</span>
###xml 55 60 <span type="species:ncbi:9606">women</span>
Loci for regulation of bone mineral density in men and women identified by genome wide linkage scan: the FAMOS study
###end article-title 107
###begin article-title 108
A whole-genome linkage scan suggests several genomic regions potentially containing quantitative trait Loci for osteoporosis
###end article-title 108
###begin article-title 109
Different combinations of cysteine-rich repeats mediate binding of low density lipoprotein receptor to two different proteins
###end article-title 109
###begin article-title 110
###xml 111 116 <span type="species:ncbi:9606">women</span>
Association study of parathyroid hormone gene polymorphism and bone mineral density in Japanese postmenopausal women
###end article-title 110
###begin article-title 111
Genetics and biology of vitamin D receptor polymorphisms
###end article-title 111
###begin article-title 112
Association of polymorphisms of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis
###end article-title 112
###begin article-title 113
Genetic determinants of bone mass
###end article-title 113
###begin article-title 114
###xml 98 103 <span type="species:ncbi:9606">women</span>
Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women
###end article-title 114
###begin article-title 115
###xml 86 89 <span type="species:ncbi:9606">men</span>
MTHFR c.677C > T polymorphism as an independent predictor of peak bone mass in Danish men-results from the Odense Androgen Study
###end article-title 115

